| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 HSP90B1 ERCC6 MYO1E DYNC2H1 DNAH2 ATP13A5 CHD8 CHD2 KATNA1 RAD50 ATP8A1 FBH1 DDX50 IQCA1 EIF4A1 CHD5 MACF1 MTREX ATP2A2 DNAH8 DDX11L8 DYNC1H1 SMC1B | 5.80e-12 | 441 | 190 | 24 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 HSP90B1 ERCC6 MYO1E DYNC2H1 MYO10 DNAH2 ATP13A5 CHD8 CHD2 KATNA1 RAD50 ACSL3 MYO3A ATP6V0D1 ATP8A1 FBH1 DDX50 IQCA1 EIF4A1 CHD5 MACF1 MTREX ATP2A2 DNAH8 DDX11L8 DYNC1H1 SMC1B | 6.04e-12 | 614 | 190 | 28 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 HSP90B1 ERCC6 MYO1E DYNC2H1 DNAH2 ATP13A5 CHD8 CHD2 KATNA1 RGS7 RAD50 RGS6 ATP8A1 FBH1 DDX50 IQCA1 EIF4A1 CHD5 MACF1 MTREX ATP2A2 DNAH8 DDX11L8 DYNC1H1 SMC1B | 2.39e-08 | 775 | 190 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 HSP90B1 ERCC6 MYO1E DYNC2H1 DNAH2 ATP13A5 CHD8 CHD2 KATNA1 RGS7 RAD50 RGS6 ATP8A1 FBH1 DDX50 IQCA1 EIF4A1 CHD5 MACF1 PGP MTREX ATP2A2 DNAH8 DDX11L8 DYNC1H1 SMC1B | 2.96e-08 | 839 | 190 | 27 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 HSP90B1 ERCC6 MYO1E DYNC2H1 DNAH2 ATP13A5 CHD8 CHD2 KATNA1 RGS7 RAD50 RGS6 ATP8A1 FBH1 DDX50 IQCA1 EIF4A1 CHD5 MACF1 PGP MTREX ATP2A2 DNAH8 DDX11L8 DYNC1H1 SMC1B | 3.03e-08 | 840 | 190 | 27 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 HSP90B1 ERCC6 MYO1E DYNC2H1 DNAH2 ATP13A5 CHD8 CHD2 KATNA1 RGS7 RAD50 RGS6 ATP8A1 FBH1 DDX50 IQCA1 EIF4A1 CHD5 MACF1 PGP MTREX ATP2A2 DNAH8 DDX11L8 DYNC1H1 SMC1B | 3.03e-08 | 840 | 190 | 27 | GO:0016818 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.73e-07 | 18 | 190 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | helicase activity | 2.84e-06 | 158 | 190 | 10 | GO:0004386 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.09e-06 | 28 | 190 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.74e-05 | 118 | 190 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.52e-05 | 37 | 190 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 9.01e-05 | 2 | 190 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase kinase binding | 1.01e-04 | 26 | 190 | 4 | GO:0031435 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.16e-04 | 127 | 190 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | plus-end directed microfilament motor activity | 2.69e-04 | 3 | 190 | 2 | GO:0060002 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.09e-04 | 62 | 190 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | GTPase activator activity | DOCK4 HTR2B TBC1D2B ADGRB3 RGS7 RGS6 RABGAP1L EIF5 PLCB1 RAPGEF2 | 3.53e-04 | 279 | 190 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | S100 protein binding | 3.55e-04 | 15 | 190 | 3 | GO:0044548 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK4 RAPGEF6 HTR2B DOCK11 TBC1D2B ADGRB3 RGS7 RGS6 TIAM1 RABGAP1L EIF2B5 EIF5 PLCB1 RAPGEF2 | 3.69e-04 | 507 | 190 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK4 RAPGEF6 HTR2B DOCK11 TBC1D2B ADGRB3 RGS7 RGS6 TIAM1 RABGAP1L EIF2B5 EIF5 PLCB1 RAPGEF2 | 3.69e-04 | 507 | 190 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.10e-04 | 37 | 190 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.43e-04 | 70 | 190 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | phospholipid binding | PITPNM2 RAPGEF6 OGT MYO1E MYO10 ANXA2 ANXA2P2 APOB TPCN1 PITPNM1 TIAM1 PLCB1 RAPGEF2 PICK1 | 7.92e-04 | 548 | 190 | 14 | GO:0005543 |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 8.84e-04 | 5 | 190 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 8.84e-04 | 5 | 190 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC6 CHD8 CHD2 RAD50 IARS2 TRMT10C POLR3B FBH1 DDX50 EIF4A1 CHD5 HARS1 MTREX CPSF3 DDX11L8 | 1.33e-03 | 645 | 190 | 15 | GO:0140640 |
| GeneOntologyMolecularFunction | phosphatidic acid binding | 1.48e-03 | 24 | 190 | 3 | GO:0070300 | |
| GeneOntologyMolecularFunction | receptor tyrosine kinase binding | 1.69e-03 | 90 | 190 | 5 | GO:0030971 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 1.83e-03 | 7 | 190 | 2 | GO:0004985 | |
| GeneOntologyBiologicalProcess | cilium movement | CACNA1E DNAH3 DYNC2H1 INPP5B DNAH2 APOB CFAP100 FSIP2 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 DYNC1H1 | 2.56e-09 | 261 | 189 | 16 | GO:0003341 |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | CACNA1E DNAH3 DYNC2H1 INPP5B DNAH2 APOB FSIP2 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 9.06e-09 | 210 | 189 | 14 | GO:0060294 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | CACNA1E DNAH3 DYNC2H1 INPP5B DNAH2 APOB FSIP2 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 1.22e-08 | 215 | 189 | 14 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | CACNA1E DNAH3 DYNC2H1 INPP5B DNAH2 APOB FSIP2 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 1.22e-08 | 215 | 189 | 14 | GO:0001539 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CACNA1A UBR1 HSP90B1 FLT3 OGT HTR2B TNFSF10 VPS13C PSMB2 SIN3A PPARA CAV2 MDM2 RGS7 IFNA14 OPRD1 OPRK1 GHSR NEFL KAT2B PTPRA TIAM1 UFD1 AGTR1 PRKAA2 EIF2B5 PLCB1 HADHA PRKDC RAPGEF2 IL1A ATP2A2 | 1.76e-07 | 1272 | 189 | 32 | GO:1901698 |
| GeneOntologyBiologicalProcess | microtubule-based movement | CACNA1E IFT140 DNAH3 DYNC2H1 INPP5B DNAH2 APOB CFAP100 FSIP2 NEFL IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 DYNC1H1 | 7.07e-07 | 493 | 189 | 18 | GO:0007018 |
| GeneOntologyBiologicalProcess | axoneme assembly | 7.29e-07 | 109 | 189 | 9 | GO:0035082 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 7.70e-07 | 56 | 189 | 7 | GO:0120316 | |
| GeneOntologyBiologicalProcess | response to carbohydrate | CACNA1E COL6A3 OGT SLC30A8 APOB SIN3A PPARA OPRK1 SIDT2 TIAM1 PRKAA2 EIF2B5 PLCB1 IL1A | 7.76e-07 | 301 | 189 | 14 | GO:0009743 |
| GeneOntologyBiologicalProcess | microtubule bundle formation | DNAH2 KATNA1 CFAP100 FSIP2 IFT88 TTC12 CFAP206 CFAP57 CFAP44 DNAH8 | 9.30e-07 | 145 | 189 | 10 | GO:0001578 |
| GeneOntologyBiologicalProcess | response to monosaccharide | CACNA1E COL6A3 OGT SLC30A8 SIN3A PPARA OPRK1 SIDT2 TIAM1 PRKAA2 EIF2B5 PLCB1 IL1A | 1.44e-06 | 272 | 189 | 13 | GO:0034284 |
| GeneOntologyBiologicalProcess | response to peptide hormone | OGT TNFSF10 VPS13C PPARA CAV2 MDM2 OPRK1 GHSR NEFL KAT2B PTPRA AGTR1 EIF2B5 PLCB1 HADHA PRKDC ATP2A2 | 8.20e-06 | 530 | 189 | 17 | GO:0043434 |
| GeneOntologyBiologicalProcess | flagellated sperm motility | CACNA1E INPP5B APOB FSIP2 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 | 8.72e-06 | 186 | 189 | 10 | GO:0030317 |
| GeneOntologyBiologicalProcess | sperm motility | CACNA1E INPP5B APOB FSIP2 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 | 1.20e-05 | 193 | 189 | 10 | GO:0097722 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | IFT140 RAPGEF6 DOCK11 DYNC2H1 MYO10 TBC1D2B DNAH2 CFAP100 FSIP2 MYO3A ATP6V0D1 IFT88 TTC12 CFAP206 CFAP61 CFAP57 RAPGEF2 CFAP44 DNAH8 | 1.36e-05 | 670 | 189 | 19 | GO:0120031 |
| GeneOntologyBiologicalProcess | sperm axoneme assembly | 1.37e-05 | 34 | 189 | 5 | GO:0007288 | |
| GeneOntologyBiologicalProcess | motile cilium assembly | 1.65e-05 | 88 | 189 | 7 | GO:0044458 | |
| GeneOntologyBiologicalProcess | cell projection assembly | IFT140 RAPGEF6 DOCK11 DYNC2H1 MYO10 TBC1D2B DNAH2 CFAP100 FSIP2 MYO3A ATP6V0D1 IFT88 TTC12 CFAP206 CFAP61 CFAP57 RAPGEF2 CFAP44 DNAH8 | 1.85e-05 | 685 | 189 | 19 | GO:0030031 |
| GeneOntologyBiologicalProcess | chromatin organization | SETD1A OGT ERCC6 RBL2 STK38 FAM47C CHD8 CHD2 NDN SIN3A ZZEF1 RAD50 KAT2B RESF1 MORF4L1 CHD5 PRKAA2 HASPIN USP7 PRKDC TAF1L KDM4B | 2.59e-05 | 896 | 189 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | response to hexose | CACNA1E COL6A3 OGT SLC30A8 SIN3A PPARA OPRK1 SIDT2 TIAM1 PRKAA2 EIF2B5 | 3.49e-05 | 265 | 189 | 11 | GO:0009746 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 3.51e-05 | 41 | 189 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CACNA1E IFT140 DNAH3 DYNC2H1 INPP5B DNAH2 APOB XPO1 KATNA1 CFAP100 FSIP2 NEFL KAT2B IQCA1 IFT88 TTC12 PRKAA2 CFAP206 MACF1 CFAP61 CFAP57 CFAP44 DNAH8 DYNC1H1 | 3.90e-05 | 1058 | 189 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | SETD1A OGT ERCC6 RBL2 STK38 FAM47C CHD8 CHD2 NDN SIN3A ZZEF1 RAD50 GTF2E1 KAT2B RESF1 MORF4L1 CHD5 PRKAA2 HASPIN USP7 PRKDC TAF1L KDM4B | 4.57e-05 | 999 | 189 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1A CACNA1E HSP90B1 OGT HK1 HTR2B SLC30A8 ATP13A5 LAMP2 BCL2 SIN3A CAV2 LGSN OPRK1 SIDT2 ATP6V0D1 TIAM1 PRKAA2 PLCB1 IL1A ATP2A2 | 4.79e-05 | 866 | 189 | 21 | GO:0055082 |
| GeneOntologyBiologicalProcess | cilium assembly | IFT140 DYNC2H1 TBC1D2B DNAH2 CFAP100 FSIP2 ATP6V0D1 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 6.34e-05 | 444 | 189 | 14 | GO:0060271 |
| GeneOntologyBiologicalProcess | response to insulin | OGT TNFSF10 VPS13C PPARA CAV2 OPRK1 GHSR KAT2B PTPRA PLCB1 HADHA PRKDC | 7.86e-05 | 342 | 189 | 12 | GO:0032868 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 8.35e-05 | 2 | 189 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | response to acrylamide | 8.35e-05 | 2 | 189 | 2 | GO:1903937 | |
| GeneOntologyBiologicalProcess | transcription-coupled nucleotide-excision repair | 8.67e-05 | 10 | 189 | 3 | GO:0006283 | |
| GeneOntologyBiologicalProcess | cellular response to monosaccharide stimulus | 1.02e-04 | 201 | 189 | 9 | GO:0071326 | |
| GeneOntologyBiologicalProcess | cilium organization | IFT140 DYNC2H1 TBC1D2B DNAH2 CFAP100 FSIP2 ATP6V0D1 IFT88 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 1.32e-04 | 476 | 189 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | response to glucose | CACNA1E COL6A3 OGT SLC30A8 SIN3A OPRK1 SIDT2 TIAM1 PRKAA2 EIF2B5 | 1.49e-04 | 260 | 189 | 10 | GO:0009749 |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.56e-04 | 125 | 189 | 7 | GO:0018210 | |
| GeneOntologyBiologicalProcess | response to gamma radiation | 1.60e-04 | 56 | 189 | 5 | GO:0010332 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | SETD1A ERCC6 FAM47C CHD8 CHD2 NDN SIN3A RAD50 KAT2B RESF1 MORF4L1 CHD5 PRKAA2 HASPIN USP7 PRKDC TAF1L KDM4B | 1.67e-04 | 741 | 189 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | cellular response to carbohydrate stimulus | 1.70e-04 | 215 | 189 | 9 | GO:0071322 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair via nonhomologous end joining | 2.01e-04 | 32 | 189 | 4 | GO:2001032 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 2.49e-04 | 3 | 189 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 2.49e-04 | 3 | 189 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 2.55e-04 | 34 | 189 | 4 | GO:0090311 | |
| GeneOntologyBiologicalProcess | endocytosis involved in viral entry into host cell | 2.56e-04 | 14 | 189 | 3 | GO:0075509 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A CACNA1E HSP90B1 OGT HK1 HTR2B SLC30A8 ATP13A5 LAMP2 BCL2 SIN3A CAV2 LGSN OPRK1 SIDT2 ATP6V0D1 TIAM1 PRKAA2 PLCB1 IL1A ATP2A2 | 2.70e-04 | 981 | 189 | 21 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CACNA1A IFT140 NRDC DOCK11 MYO10 TBC1D2B ADGRB3 PLXND1 KATNA1 MDM2 NEFL MYO3A KAT2B ARSB PTPRG TIAM1 IFT88 MACF1 RAPGEF2 | 2.97e-04 | 846 | 189 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | protein processing | HSP90B1 OGT DYNC2H1 ANXA2 INPP5B SLC30A8 MDM2 ACE2 IFT88 PRKACB | 3.11e-04 | 285 | 189 | 10 | GO:0016485 |
| GeneOntologyBiologicalProcess | regulation of plasma lipoprotein particle levels | 3.74e-04 | 103 | 189 | 6 | GO:0097006 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CACNA1A IFT140 NRDC DOCK11 MYO10 TBC1D2B ADGRB3 PLXND1 KATNA1 MDM2 NEFL MYO3A KAT2B ARSB PTPRG TIAM1 IFT88 MACF1 RAPGEF2 | 3.79e-04 | 863 | 189 | 19 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via nonhomologous end joining | 4.68e-04 | 17 | 189 | 3 | GO:2001034 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A CACNA1E HSP90B1 OGT HK1 HTR2B SLC30A8 ATP13A5 LAMP2 APOB BCL2 SIN3A CAV2 LGSN OPRK1 SIDT2 ATP6V0D1 TIAM1 AGTR1 PRKAA2 PRKACB PLCB1 IL1A ATP2A2 | 4.77e-04 | 1249 | 189 | 24 | GO:0048878 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 4.89e-04 | 71 | 189 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 4.95e-04 | 4 | 189 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 4.95e-04 | 4 | 189 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 4.95e-04 | 4 | 189 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 4.95e-04 | 4 | 189 | 2 | GO:0032382 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | OGT NRDC ANXA2 ANXA2P2 VPS13C TM9SF1 LAMP2 APOB BCL2 PPARA CPT1B SUCLA2 TPCN1 QSOX1 KAT2B ATP6V0D1 ARSB IFT88 PRKAA2 UGT2B4 PLCB1 HADHA STK38L ATP2A2 | 4.99e-04 | 1253 | 189 | 24 | GO:0044248 |
| GeneOntologyBiologicalProcess | TORC1 signaling | 5.07e-04 | 109 | 189 | 6 | GO:0038202 | |
| GeneOntologyBiologicalProcess | cellular response to hexose stimulus | 5.12e-04 | 199 | 189 | 8 | GO:0071331 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 5.57e-04 | 307 | 189 | 10 | GO:0018105 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor recycling | 5.58e-04 | 18 | 189 | 3 | GO:0001921 | |
| GeneOntologyBiologicalProcess | response to hormone | FLT3 OGT TNFSF10 VPS13C BCL2 PPARA CAV2 MDM2 OPRK1 GHSR NEFL KAT2B PTPRA ARSB AGTR1 PRKAA2 EIF2B5 PLCB1 HADHA PRKDC ATP2A2 | 5.97e-04 | 1042 | 189 | 21 | GO:0009725 |
| GeneOntologyBiologicalProcess | protein maturation | HSP90B1 OGT DYNC2H1 ANXA2 INPP5B SLC30A8 MDM2 F8 ACE2 QSOX1 NAA35 KAT2B IFT88 PDCD5 PRKACB | 6.04e-04 | 619 | 189 | 15 | GO:0051604 |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | TCEA1 SETD1A FLT3 OGT ERCC6 NRDC DOCK11 NBEA NDN BCL2 VSTM4 IFT88 PRKAA2 PRKACB PLCB1 CARD11 PRKDC FH IL1A DYNC1H1 DYRK3 | 6.05e-04 | 1043 | 189 | 21 | GO:0048871 |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 6.73e-04 | 115 | 189 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | NRDC TNFSF10 DOCK11 ANXA2 ANXA2P2 ADGRB3 PLXND1 RAD50 ACE2 NEFL MYO3A KAT2B ARSB RESF1 ATP8A1 TIAM1 BAIAP2L1 IFT88 PDCD5 PLCB1 MACF1 RAPGEF2 IL1A DYNC1H1 PICK1 | 7.35e-04 | 1366 | 189 | 25 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | CACNA1E OGT ANXA2 ANXA2P2 SLC30A8 NBEA BCL2 SIN3A XPO1 CAV2 MDM2 GHSR ACSL3 SIDT2 TIAM1 PDCD5 RABGAP1L PRKAA2 USP7 PLCB1 IL1A DYNC1H1 PICK1 | 7.46e-04 | 1212 | 189 | 23 | GO:0060341 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 7.49e-04 | 319 | 189 | 10 | GO:0018209 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 8.06e-04 | 119 | 189 | 6 | GO:1901796 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane repair | 8.20e-04 | 5 | 189 | 2 | GO:1905686 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor binding | 8.20e-04 | 5 | 189 | 2 | GO:1905595 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular lipid transport | 8.20e-04 | 5 | 189 | 2 | GO:0032379 | |
| GeneOntologyBiologicalProcess | lipid transport | PITPNM2 ANXA2 ANXA2P2 VPS13C APOB PPARA CPT1B STARD6 PITPNM1 ACSL3 ATP8A1 AGTR1 IL1A | 8.22e-04 | 506 | 189 | 13 | GO:0006869 |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 8.35e-04 | 165 | 189 | 7 | GO:0045834 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid biosynthetic process | 8.79e-04 | 121 | 189 | 6 | GO:0046889 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell differentiation | 8.95e-04 | 47 | 189 | 4 | GO:0060218 | |
| GeneOntologyBiologicalProcess | protein deacetylation | 8.95e-04 | 47 | 189 | 4 | GO:0006476 | |
| GeneOntologyBiologicalProcess | homeostasis of number of cells | TCEA1 SETD1A FLT3 DOCK11 NBEA BCL2 IFT88 PLCB1 CARD11 PRKDC FH DYRK3 | 9.09e-04 | 448 | 189 | 12 | GO:0048872 |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 9.29e-04 | 218 | 189 | 8 | GO:0001678 | |
| GeneOntologyBiologicalProcess | regulation of protein processing | 9.45e-04 | 82 | 189 | 5 | GO:0070613 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | ERCC6 RBL2 STK38 BCL2 SIN3A MDM2 RAD50 HASPIN PLCB1 PRKDC IK CPSF3 DYRK3 | 9.82e-04 | 516 | 189 | 13 | GO:1901987 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | DNAH2 XPO1 KATNA1 CFAP100 FSIP2 NEFL KAT2B IQCA1 IFT88 TTC12 PRKAA2 CFAP206 CFAP57 CFAP44 DNAH8 DYNC1H1 | 1.00e-03 | 720 | 189 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of tubulin deacetylation | 1.03e-03 | 22 | 189 | 3 | GO:0090043 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | RAPGEF6 DOCK11 TBC1D2B PLXND1 CAV2 RGS7 RGS6 TIAM1 RABGAP1L RAPGEF2 | 1.08e-03 | 335 | 189 | 10 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of protein binding | 1.11e-03 | 85 | 189 | 5 | GO:0032092 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | CACNA1A CACNA1E OGT HK1 SLC30A8 SIN3A OPRK1 SIDT2 TIAM1 PRKAA2 | 1.16e-03 | 338 | 189 | 10 | GO:0042593 |
| GeneOntologyBiologicalProcess | regulation of protein maturation | 1.17e-03 | 86 | 189 | 5 | GO:1903317 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | CACNA1A CACNA1E OGT HK1 SLC30A8 SIN3A OPRK1 SIDT2 TIAM1 PRKAA2 | 1.19e-03 | 339 | 189 | 10 | GO:0033500 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein receptor activity | 1.22e-03 | 6 | 189 | 2 | GO:1905599 | |
| GeneOntologyBiologicalProcess | B cell lineage commitment | 1.22e-03 | 6 | 189 | 2 | GO:0002326 | |
| GeneOntologyBiologicalProcess | nitrogen utilization | 1.22e-03 | 6 | 189 | 2 | GO:0019740 | |
| GeneOntologyBiologicalProcess | intracellular nitrogen homeostasis | 1.22e-03 | 6 | 189 | 2 | GO:0141067 | |
| GeneOntologyBiologicalProcess | positive regulation of eating behavior | 1.22e-03 | 6 | 189 | 2 | GO:1904000 | |
| GeneOntologyBiologicalProcess | spermatid nucleus elongation | 1.22e-03 | 6 | 189 | 2 | GO:0007290 | |
| GeneOntologyCellularComponent | lipid droplet | 1.11e-05 | 116 | 190 | 8 | GO:0005811 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | TCEA1 CUL2 UBR1 LZTR1 OGT RPAP3 PSMB2 ELP1 GTF2E1 NAA35 KAT2B TRMT10C POLR3B FBH1 MORF4L1 EIF4A1 PRKAA2 PRKACB CARD11 PRKDC FBXO21 TAF1L | 7.73e-05 | 972 | 190 | 22 | GO:0140535 |
| GeneOntologyCellularComponent | motile cilium | DNAH3 DYNC2H1 DNAH2 CFAP100 FSIP2 IQCA1 IFT88 CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 1.04e-04 | 355 | 190 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | axoneme | IFT140 DNAH3 DYNC2H1 DNAH2 CFAP100 IFT88 CFAP206 CFAP61 DNAH8 | 1.21e-04 | 207 | 190 | 9 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | IFT140 DNAH3 DYNC2H1 DNAH2 CFAP100 IFT88 CFAP206 CFAP61 DNAH8 | 1.25e-04 | 208 | 190 | 9 | GO:0097014 |
| GeneOntologyCellularComponent | dynein complex | 1.30e-04 | 54 | 190 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | IFT140 DNAH3 DYNC2H1 DNAH2 CFAP100 NEFL IFT88 CFAP206 CFAP61 DNAH8 DYNC1H1 | 1.61e-04 | 317 | 190 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | transferase complex | TCEA1 CUL2 UBR1 SETD1A LZTR1 OGT CHD8 PHKB GTF2E1 NAA35 KAT2B TRMT10C POLR3B FBH1 MORF4L1 PRKAA2 PRKACB HADHA PRKDC FBXO21 TAF1L | 1.89e-04 | 963 | 190 | 21 | GO:1990234 |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 2.45e-04 | 3 | 190 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 2.45e-04 | 3 | 190 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | cytoplasmic region | IFT140 DNAH3 DYNC2H1 DNAH2 CFAP100 NEFL IFT88 CFAP206 CFAP61 DNAH8 DYNC1H1 | 4.75e-04 | 360 | 190 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TCEA1 SETD1A MIS18BP1 GCFC2 OGT ERCC6 TENT4A ANXA2 ANXA2P2 CHD8 SIN3A XAB2 RAD50 INTS10 GTF2E1 POLR3B MORF4L1 CHD5 WDR12 PRKDC MTREX IK TAF1L CPSF3 DDX11L8 | 7.36e-04 | 1377 | 190 | 25 | GO:0140513 |
| GeneOntologyCellularComponent | TRAMP complex | 8.07e-04 | 5 | 190 | 2 | GO:0031499 | |
| GeneOntologyCellularComponent | endocytic vesicle | HSP90B1 RAPGEF6 MYO1E INPP5B LAMP2 APOB MDM2 ACE2 ATP6V0D1 RAPGEF2 PICK1 | 8.10e-04 | 384 | 190 | 11 | GO:0030139 |
| GeneOntologyCellularComponent | Sin3-type complex | 1.00e-03 | 22 | 190 | 3 | GO:0070822 | |
| GeneOntologyCellularComponent | cilium | ANO2 IFT140 DNAH3 DYNC2H1 DNAH2 PPEF2 CFAP100 FSIP2 ACE2 TIAM1 IQCA1 IFT88 PRKACB CFAP206 CFAP61 CFAP57 CFAP44 DNAH8 | 1.44e-03 | 898 | 190 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.47e-03 | 25 | 190 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.55e-03 | 238 | 190 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 1.67e-03 | 7 | 190 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MGAM FLT3 LZTR1 ANXA2 ANXA2P2 VPS13C INPP5B SLC30A8 AP1M2 ATP13A5 LAMP2 APOB CAV2 MDM2 ITGAX OPRD1 OPRK1 TPCN1 ACE2 ATP6V0D1 ATP8A1 IFT88 PICK1 | 1.82e-03 | 1307 | 190 | 23 | GO:0030659 |
| MousePheno | short sperm flagellum | 4.98e-06 | 63 | 151 | 7 | MP:0009239 | |
| MousePheno | kinked sperm flagellum | 2.99e-05 | 56 | 151 | 6 | MP:0009237 | |
| MousePheno | coiled sperm flagellum | 5.37e-05 | 62 | 151 | 6 | MP:0009238 | |
| MousePheno | abnormal outer dense fiber morphology | 5.89e-05 | 39 | 151 | 5 | MP:0031356 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.77e-07 | 14 | 187 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.77e-07 | 14 | 187 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.77e-07 | 14 | 187 | 5 | IPR013602 | |
| Domain | DHC_N2 | 1.77e-07 | 14 | 187 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.77e-07 | 14 | 187 | 5 | IPR011704 | |
| Domain | MT | 1.77e-07 | 14 | 187 | 5 | PF12777 | |
| Domain | AAA_8 | 1.77e-07 | 14 | 187 | 5 | PF12780 | |
| Domain | AAA_5 | 1.77e-07 | 14 | 187 | 5 | PF07728 | |
| Domain | DHC_fam | 2.64e-07 | 15 | 187 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 2.64e-07 | 15 | 187 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.64e-07 | 15 | 187 | 5 | IPR004273 | |
| Domain | DHC_N1 | 6.60e-07 | 8 | 187 | 4 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.60e-07 | 8 | 187 | 4 | IPR013594 | |
| Domain | TPR_8 | 1.44e-05 | 53 | 187 | 6 | PF13181 | |
| Domain | P-loop_NTPase | DNAH3 ERCC6 MYO1E DYNC2H1 MYO10 DNAH2 CHD8 CHD2 KATNA1 RAD50 MYO3A FBH1 DDX50 IQCA1 EIF4A1 CHD5 SRL CARD11 MTREX DNAH8 DYNC1H1 SMC1B | 4.23e-05 | 848 | 187 | 22 | IPR027417 |
| Domain | - | DNAH3 ERCC6 MYO1E DYNC2H1 DNAH2 CHD8 CHD2 KATNA1 RAD50 FBH1 DDX50 IQCA1 EIF4A1 CHD5 SRL CARD11 MTREX DNAH8 DYNC1H1 SMC1B | 6.15e-05 | 746 | 187 | 20 | 3.40.50.300 |
| Domain | Pentatricopeptide_repeat | 7.42e-05 | 23 | 187 | 4 | IPR002885 | |
| Domain | Helicase_C | 1.01e-04 | 107 | 187 | 7 | PF00271 | |
| Domain | HELICc | 1.01e-04 | 107 | 187 | 7 | SM00490 | |
| Domain | Helicase_C | 1.07e-04 | 108 | 187 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 1.14e-04 | 109 | 187 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.14e-04 | 109 | 187 | 7 | PS51192 | |
| Domain | DEXDc | 1.14e-04 | 109 | 187 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.20e-04 | 110 | 187 | 7 | IPR014001 | |
| Domain | TPR-contain_dom | 1.36e-04 | 150 | 187 | 8 | IPR013026 | |
| Domain | HAD-like_dom | 1.41e-04 | 79 | 187 | 6 | IPR023214 | |
| Domain | TPR_REGION | 2.62e-04 | 165 | 187 | 8 | PS50293 | |
| Domain | TPR | 2.62e-04 | 165 | 187 | 8 | PS50005 | |
| Domain | SNF2_N | 2.81e-04 | 32 | 187 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.81e-04 | 32 | 187 | 4 | PF00176 | |
| Domain | Chromodomain-like | 2.81e-04 | 32 | 187 | 4 | IPR016197 | |
| Domain | - | 4.51e-04 | 64 | 187 | 5 | 3.40.50.1000 | |
| Domain | Opioid_rcpt | 5.90e-04 | 4 | 187 | 2 | IPR001418 | |
| Domain | IP_trans | 9.78e-04 | 5 | 187 | 2 | PF02121 | |
| Domain | LNS2 | 1.46e-03 | 6 | 187 | 2 | IPR013209 | |
| Domain | PI_transfer | 1.46e-03 | 6 | 187 | 2 | IPR001666 | |
| Domain | LNS2 | 1.46e-03 | 6 | 187 | 2 | SM00775 | |
| Domain | DDHD | 1.46e-03 | 6 | 187 | 2 | PF02862 | |
| Domain | DDHD | 1.46e-03 | 6 | 187 | 2 | PS51043 | |
| Domain | DDHD_dom | 1.46e-03 | 6 | 187 | 2 | IPR004177 | |
| Domain | LNS2 | 1.46e-03 | 6 | 187 | 2 | PF08235 | |
| Domain | LNS2/PITP | 1.46e-03 | 6 | 187 | 2 | IPR031315 | |
| Domain | DDHD | 1.46e-03 | 6 | 187 | 2 | SM01127 | |
| Domain | - | 1.51e-03 | 23 | 187 | 3 | 3.30.530.20 | |
| Domain | START-like_dom | 1.51e-03 | 23 | 187 | 3 | IPR023393 | |
| Pubmed | RPL30 HK1 PHRF1 NOC3L ELP1 CHD8 CHD2 URB2 XPO1 XAB2 RAD50 ACSL3 NEFL IARS2 EIF4A1 USP7 MACF1 WDR12 HADHA PRKDC MTREX IK FH ATP2A2 CPSF3 DYNC1H1 CAP1 | 4.16e-16 | 653 | 191 | 27 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL30 HSP90B1 HK1 NRDC DYNC2H1 ANXA2 VPS13C PSMB2 NOC3L ELP1 APOB URB2 XPO1 NCLN SUCLA2 RAD50 ACSL3 IARS2 TRMT10C ATP6V0D1 DDX50 EIF4A1 PRKAA2 EIF2B5 EIF5 USP7 WDR12 HADHA PRKDC HARS1 MTREX IK FH ATP2A2 CPSF3 DYNC1H1 CAP1 | 2.83e-15 | 1425 | 191 | 37 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 SETD1A RPL30 HSP90B1 MIS18BP1 HK1 ERCC6 RPAP3 PSMB2 NOC3L ELP1 CHD8 CHD2 URB2 XPO1 RAD50 ACSL3 NAA35 POLR3B DDX50 EIF4A1 UFD1 EIF2B5 USP7 MACF1 HADHA PRKDC PGP MTREX IK ATP2A2 CPSF3 DYNC1H1 CAP1 | 1.13e-13 | 1353 | 191 | 34 | 29467282 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | COL6A3 HK1 RBL2 ANXA2P2 ELP1 LAMP2 XPO1 RAD50 IARS2 USP7 HADHA PRKDC MTREX | 2.46e-11 | 179 | 191 | 13 | 36261009 |
| Pubmed | CUL2 UBR1 RPL30 RAPGEF6 OGT NRDC RPAP3 ELP1 CHD8 SIN3A NCLN ZZEF1 XAB2 ACE2 SLC25A32 EIF4A1 EIF2B5 GALNT6 MTREX ZC3H7B DDX11L8 | 9.48e-11 | 650 | 191 | 21 | 38777146 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL30 HSP90B1 OGT NRDC MYO1E RPAP3 ANXA2 PSMB2 ELP1 SIN3A XPO1 NCLN XAB2 RAD50 GTF2E1 TRMT10C BAIAP2L1 MORF4L1 EIF4A1 UFD1 NIP7 USP7 MACF1 HADHA PRKDC PGP MTREX IK ATP2A2 DYNC1H1 | 2.35e-10 | 1415 | 191 | 30 | 28515276 |
| Pubmed | CUL2 HK1 NRDC ELP1 SIN3A XPO1 XAB2 RAD50 ACSL3 INTS10 TRMT10C POLR3B ATP6V0D1 BAIAP2L1 EIF2B5 HADHA MTREX IK DYNC1H1 | 3.46e-10 | 560 | 191 | 19 | 35241646 | |
| Pubmed | CUL2 HSP90B1 NRDC ANXA2 APEH LAMP2 APOB URB2 XPO1 NCLN XAB2 ACSL3 NAA35 TRMT10C ATP6V0D1 DDX50 MORF4L1 EIF4A1 PDCD5 EIF5 MACF1 WDR12 HADHA PRKDC HARS1 ATP2A2 CPSF3 DYNC1H1 | 6.72e-10 | 1297 | 191 | 28 | 33545068 | |
| Pubmed | RPL30 DNAH3 HSP90B1 HK1 ANXA2 VPS13C NOC3L APEH LAMP2 XPO1 NCLN SUCLA2 NEFL IARS2 EIF4A1 UFD1 HADHA PRKDC FH ATP2A2 DYNC1H1 CAP1 | 7.33e-10 | 803 | 191 | 22 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSP90B1 HK1 DYNC2H1 ANXA2 PSMB2 AP1M2 CHD8 ZZEF1 NAA35 IARS2 EIF4A1 UFD1 USP7 MACF1 PCNX1 HADHA PRKDC HARS1 FH ATP2A2 DYNC1H1 CAP1 | 8.04e-10 | 807 | 191 | 22 | 30575818 |
| Pubmed | HSP90B1 LZTR1 RPAP3 PSMB2 NOC3L ELP1 NBEA XPO1 PPEF2 ACSL3 PHKB NEFL GTF2E1 TRMT10C PTPRA DDX50 PTPRG TIAM1 USP7 HADHA PGP HARS1 IK ATP2A2 CPSF3 | 8.29e-10 | 1049 | 191 | 25 | 27880917 | |
| Pubmed | TCEA1 GCFC2 HK1 NRDC TENT4A RPAP3 ELP1 LAMP2 XPO1 NCLN XAB2 ACSL3 DDX50 UFD1 HADHA PRKDC MTREX IK CPSF3 | 4.31e-09 | 653 | 191 | 19 | 33742100 | |
| Pubmed | CUL2 SETD1A HK1 TENT4A DNAH2 STK38 PLXND1 MDM2 ACSL3 KAT2B POLR3B PTPRA ATP8A1 EIF4A1 PRKACB PLCB1 GALNT6 HARS1 STK38L TAF1L | 4.56e-09 | 730 | 191 | 20 | 34857952 | |
| Pubmed | CACNA1A PITPNM2 RPL30 HSP90B1 OGT HK1 NRDC MYO1E ANXA2 ANXA2P2 ELP1 NBEA XPO1 SUCLA2 PITPNM1 PHKB NEFL ATP6V0D1 PTPRA ATP8A1 USP7 MACF1 HADHA RAPGEF2 FH ATP2A2 DYNC1H1 CAP1 | 5.80e-09 | 1431 | 191 | 28 | 37142655 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL30 HSP90B1 ANXA2 NOC3L SIN3A URB2 XPO1 XAB2 RAD50 TRMT10C DDX50 MORF4L1 EIF4A1 UFD1 NIP7 USP7 WDR12 HADHA PRKDC MTREX IK ATP2A2 CPSF3 | 6.56e-09 | 989 | 191 | 23 | 36424410 |
| Pubmed | CUL2 RPL30 HSP90B1 HK1 MYO1E PSMB2 NOC3L ELP1 XPO1 NCLN SUCLA2 RAD50 ACSL3 IARS2 TRMT10C POLR3B ATP6V0D1 DDX50 EIF4A1 UFD1 NIP7 EIF2B5 USP7 HADHA PRKDC MTREX ATP2A2 DYNC1H1 | 6.63e-09 | 1440 | 191 | 28 | 30833792 | |
| Pubmed | PITPNM2 SETD1A IFT140 VPS13C PHRF1 TBC1D2B ADGRB3 CHD8 PLXND1 ZZEF1 TPCN1 CHD5 PLCB1 PCNX1 MTREX ZC3H7B KDM4B | 6.86e-09 | 529 | 191 | 17 | 14621295 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL30 HSP90B1 ERCC6 MYO1E RPAP3 ANXA2 NOC3L XPO1 CAV2 XAB2 RAD50 IARS2 TRMT10C DDX50 BAIAP2L1 EIF4A1 CHD5 NIP7 EIF5 USP7 WDR12 HADHA PRKDC MTREX IK DYNC1H1 | 7.01e-09 | 1257 | 191 | 26 | 36526897 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TCEA1 CUL2 RPL30 HSP90B1 OGT HK1 NRDC MYO1E ANXA2 PSMB2 ELP1 THUMPD1 APEH LAMP2 XPO1 ZZEF1 GTF2E1 UFD1 EIF5 PRKACB USP7 MACF1 WDR12 PRKDC HARS1 FH DYNC1H1 CAP1 | 8.29e-09 | 1455 | 191 | 28 | 22863883 |
| Pubmed | 9.12e-09 | 14 | 191 | 5 | 9373155 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | CUL2 UBR1 AMPD1 HK1 ANXA2 PSMB2 NOC3L THUMPD1 APEH LAMP2 SIN3A XPO1 SUCLA2 XAB2 RAD50 ACSL3 IARS2 TRMT10C ATP6V0D1 BAIAP2L1 EIF4A1 EIF5 HADHA PRKDC FH ATP2A2 CPSF3 | 9.19e-09 | 1367 | 191 | 27 | 32687490 |
| Pubmed | TCEA1 CUL2 MIS18BP1 OGT ANXA2 PSMB2 THUMPD1 CHD8 CHD2 SIN3A XPO1 XAB2 RAD50 GTF2E1 POLR3B EIF4A1 PDCD5 UFD1 USP7 PRKDC MTREX IK CPSF3 | 1.04e-08 | 1014 | 191 | 23 | 32416067 | |
| Pubmed | HSP90B1 OGT MYO1E RBL2 ADGRB3 APEH NBEA XAB2 PLEKHH1 NEFL POLR3B PTPRA FBH1 TIAM1 IFT88 MORF4L1 EIF4A1 ARID5B USP7 MACF1 PRKDC HARS1 RAPGEF2 ATP2A2 DYNC1H1 PICK1 | 1.10e-08 | 1285 | 191 | 26 | 35914814 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | HK1 ELP1 THUMPD1 SIN3A URB2 SUCLA2 RAD50 IARS2 POLR3B EIF4A1 NIP7 EIF5 HADHA PRKDC MTREX IK ZC3H7B DNAH8 DYNC1H1 | 1.44e-08 | 704 | 191 | 19 | 29955894 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SETD1A HSP90B1 OGT NOC3L CHD8 CHD2 SIN3A XPO1 DDX50 NIP7 USP7 WDR12 HADHA PRKDC | 4.50e-08 | 394 | 191 | 14 | 27248496 |
| Pubmed | OGT ERCC6 PSMB2 PHRF1 NOC3L LAMP2 CHD8 CHD2 URB2 XAB2 INTS10 TRMT10C ATP6V0D1 DDX50 PTCD1 MORF4L1 EIF4A1 NIP7 EIF5 USP7 MACF1 WDR12 MTREX IK ZC3H7B ATP2A2 TAF1L | 5.94e-08 | 1497 | 191 | 27 | 31527615 | |
| Pubmed | COL6A3 DYNC2H1 STK38 ZZEF1 NEFL EIF4A1 PLCB1 ZNF616 CFAP44 DNAH8 | 9.59e-08 | 187 | 191 | 10 | 26460568 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TCEA1 RPL30 HSP90B1 OGT HK1 ANXA2 STK38 XPO1 RAD50 PHKB NEFL EIF4A1 PDCD5 EIF5 USP7 MACF1 HADHA PRKDC HARS1 STK38L ATP2A2 DYNC1H1 CAP1 | 1.00e-07 | 1149 | 191 | 23 | 35446349 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DNAH3 HSP90B1 HK1 ANXA2 PSMB2 DNAH2 ADGRB3 RAD50 NEFL TRMT10C POLR3B EIF4A1 PDCD5 RABGAP1L EIF5 MACF1 PRKDC HARS1 DYNC1H1 | 2.55e-07 | 847 | 191 | 19 | 35235311 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TCEA1 UBR1 RAPGEF6 GCFC2 PHRF1 SIN3A XPO1 RAD50 PITPNM1 ACSL3 QSOX1 MYO3A PDCD5 EIF2B5 USP7 PRKDC ATP2A2 KDM4B | 3.19e-07 | 774 | 191 | 18 | 15302935 |
| Pubmed | MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24. | 3.30e-07 | 50 | 191 | 6 | 24980433 | |
| Pubmed | DOCK4 CACNA1A PITPNM2 HSP90B1 ANXA2 ANXA2P2 ADGRB3 NBEA NCLN SUCLA2 PITPNM1 ACSL3 TRMT10C ATP6V0D1 PDCD5 RABGAP1L USP7 PLCB1 MACF1 HADHA ATP2A2 CAP1 | 3.56e-07 | 1139 | 191 | 22 | 36417873 | |
| Pubmed | CUL2 RPL30 HSP90B1 NRDC RPAP3 ANXA2 PSMB2 ELP1 XPO1 RAD50 TRMT10C RESF1 IFT88 PTCD1 MORF4L1 EIF4A1 UFD1 PRKACB USP7 PCNX1 HADHA PRKDC MTREX ATP2A2 | 3.67e-07 | 1335 | 191 | 24 | 29229926 | |
| Pubmed | CACNA1E RPL30 HSP90B1 HK1 ANXA2 NOC3L DNAH2 CHD2 APOB CAGE1 PPARA ACSL3 NEFL DDX50 IFT88 EIF4A1 CHD5 NIP7 PRKACB MACF1 HADHA PRKDC ATP2A2 DNAH8 PICK1 | 4.01e-07 | 1442 | 191 | 25 | 35575683 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 4.28e-07 | 84 | 191 | 7 | 25670202 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CUL2 RPL30 HSP90B1 OGT HK1 ANXA2 ANXA2P2 PSMB2 ELP1 XPO1 NCLN SUCLA2 ACSL3 IARS2 EIF4A1 UFD1 USP7 HADHA PRKDC IK ATP2A2 CPSF3 DYNC1H1 | 4.85e-07 | 1257 | 191 | 23 | 37317656 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | PITPNM2 CACNA1E ANXA2 ANXA2P2 NBEA PITPNM1 NEFL PRKACB MACF1 RAPGEF2 DYNC1H1 | 5.03e-07 | 281 | 191 | 11 | 28706196 |
| Pubmed | CACNA1A CACNA1E ADGRB3 NBEA SUCLA2 RGS7 PITPNM1 ATP8A1 PRKACB PLCB1 MACF1 ATP2A2 | 5.65e-07 | 347 | 191 | 12 | 17114649 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSP90B1 OGT HK1 ANXA2 STK38 CHD2 XPO1 XAB2 NEFL TRMT10C DDX50 MORF4L1 EIF4A1 USP7 MACF1 HADHA PRKDC IK ATP2A2 CPSF3 DYNC1H1 | 6.19e-07 | 1082 | 191 | 21 | 38697112 |
| Pubmed | 7.17e-07 | 31 | 191 | 5 | 26678539 | ||
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 7.17e-07 | 31 | 191 | 5 | 25838543 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 8.21e-07 | 182 | 191 | 9 | 30711629 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PITPNM2 SETD1A RAPGEF6 LZTR1 MYO1E MYO10 APEH CHD8 PPARA PLXND1 NCLN ZZEF1 TPCN1 CHD5 USP40 USP7 PCNX1 PRKDC ZC3H7B DYNC1H1 PICK1 | 8.67e-07 | 1105 | 191 | 21 | 35748872 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | DOCK4 MIS18BP1 OGT DYNC2H1 TBC1D2B ELP1 MDM2 RAD50 RESF1 BAIAP2L1 ARID5B USP7 MACF1 MTREX CFAP44 | 1.03e-06 | 588 | 191 | 15 | 38580884 |
| Pubmed | CUL2 HSP90B1 HK1 TBC1D2B XPO1 PTPRA BAIAP2L1 RABGAP1L PRKAA2 EIF5 USP7 HADHA PRKDC | 1.03e-06 | 437 | 191 | 13 | 20562859 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A RPL30 HSP90B1 OGT NOC3L CHD8 CHD2 NCLN SUCLA2 XAB2 SLC25A32 TRMT10C DDX50 EIF4A1 NIP7 WDR12 HADHA PRKDC MTREX FH ATP2A2 CPSF3 DYNC1H1 | 1.09e-06 | 1318 | 191 | 23 | 30463901 |
| Pubmed | RPL30 HSP90B1 ANXA2 ANXA2P2 PSMB2 XPO1 NCLN ACSL3 QSOX1 MYO3A PTCD1 EIF4A1 MACF1 HADHA PRKDC HARS1 DYNC1H1 CAP1 | 1.10e-06 | 844 | 191 | 18 | 25963833 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL30 ERCC6 ANXA2 NOC3L SIN3A URB2 XPO1 POLR3B DDX50 EIF4A1 EIF2B5 MACF1 WDR12 PRKDC MTREX IK ZC3H7B | 1.15e-06 | 759 | 191 | 17 | 35915203 |
| Pubmed | Gene structure and chromosome mapping of mouse transcription elongation factor S-II (Tcea1). | 1.62e-06 | 5 | 191 | 3 | 10689187 | |
| Pubmed | Monoubiquitylation promotes mitochondrial p53 translocation. | 1.62e-06 | 5 | 191 | 3 | 17268548 | |
| Pubmed | DOCK4 RAPGEF6 STK38 NEFL TIAM1 BAIAP2L1 PRKDC STK38L CPSF3 DYNC1H1 | 1.65e-06 | 255 | 191 | 10 | 15324660 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPL30 HSP90B1 ANXA2 STK38 LAMP2 XPO1 XAB2 ACSL3 DDX50 EIF4A1 HADHA PRKDC MTREX IK CPSF3 DYNC1H1 | 2.39e-06 | 714 | 191 | 16 | 28302793 |
| Pubmed | OGT DOCK11 STK38 XPO1 RAD50 PDCD5 USP7 WDR12 PRKDC MTREX STK38L DYNC1H1 | 2.42e-06 | 399 | 191 | 12 | 37536630 | |
| Pubmed | CUL2 RPL30 HSP90B1 HK1 RPAP3 DYNC2H1 PSMB2 NOC3L ELP1 APEH NCLN SUCLA2 ACSL3 NAA35 IARS2 TRMT10C TIAM1 PTCD1 NIP7 PRKACB MACF1 WDR12 HADHA ATP2A2 | 2.43e-06 | 1487 | 191 | 24 | 33957083 | |
| Pubmed | HSP90B1 OGT ANXA2 STK38 XAB2 RAD50 PHKB NEFL EIF4A1 PRKDC MTREX IK FH STK38L | 2.49e-06 | 551 | 191 | 14 | 34728620 | |
| Pubmed | 2.54e-06 | 18 | 191 | 4 | 27984743 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | OGT ANXA2 PHRF1 CHD2 SIN3A NCLN XAB2 RAD50 ACSL3 INTS10 DDX50 MORF4L1 NIP7 ARID5B USP7 HADHA PRKDC MTREX IK ATP2A2 TAF1L CPSF3 | 2.89e-06 | 1294 | 191 | 22 | 30804502 |
| Pubmed | MIS18BP1 OGT NOC3L CHD8 SIN3A XAB2 MORF4L1 UFD1 USP7 MTREX IK | 3.11e-06 | 339 | 191 | 11 | 30415952 | |
| Pubmed | 3.22e-06 | 6 | 191 | 3 | 26182056 | ||
| Pubmed | TCEA1 OGT PSMB2 APEH CHD8 SIN3A XPO1 RAD50 RESF1 MORF4L1 EIF4A1 PDCD5 EIF5 HADHA PRKDC MTREX IK ATP2A2 DYNC1H1 CAP1 | 3.26e-06 | 1103 | 191 | 20 | 34189442 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | HSP90B1 OGT HK1 ANXA2 ANXA2P2 VPS13C PSMB2 PITPNM1 IFT88 PRKACB HADHA PRKDC FH ATP2A2 | 3.26e-06 | 564 | 191 | 14 | 21565611 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | HSP90B1 OGT ANXA2 PSMB2 XPO1 NCLN RAD50 ACSL3 EIF4A1 USP7 PRKDC MTREX ATP2A2 DYNC1H1 | 3.76e-06 | 571 | 191 | 14 | 37167062 |
| Pubmed | IFT140 LZTR1 OGT ERCC6 PHRF1 CHD8 SIN3A MDM2 ZZEF1 RAD50 INTS10 NAA35 KAT2B ARSB RESF1 MORF4L1 CHD5 USP7 MACF1 RAPGEF2 | 3.88e-06 | 1116 | 191 | 20 | 31753913 | |
| Pubmed | 3.92e-06 | 220 | 191 | 9 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 3.92e-06 | 220 | 191 | 9 | 35785414 | |
| Pubmed | RPL30 HSP90B1 OGT PSMB2 ELP1 XPO1 NCLN ZZEF1 UFD1 EIF2B5 EIF5 PCNX1 PRKDC STK38L ATP2A2 | 3.98e-06 | 657 | 191 | 15 | 36180527 | |
| Pubmed | TCEA1 ANXA2 URB2 XPO1 RAD50 DDX50 MORF4L1 NIP7 WDR12 PRKDC MTREX DYNC1H1 | 3.98e-06 | 419 | 191 | 12 | 15635413 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSP90B1 ANXA2 ELP1 URB2 XPO1 NCLN XAB2 RAD50 ACSL3 NEFL DDX50 EIF4A1 MACF1 HADHA PRKDC MTREX IK ATP2A2 DYNC1H1 | 4.19e-06 | 1024 | 191 | 19 | 24711643 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | HSP90B1 MYO1E ANXA2 STK38 XPO1 ACSL3 TRMT10C ATP6V0D1 PRKDC ATP2A2 CPSF3 DYNC1H1 | 4.28e-06 | 422 | 191 | 12 | 27342126 |
| Pubmed | 4.70e-06 | 225 | 191 | 9 | 12168954 | ||
| Pubmed | HSP90B1 RAPGEF6 HK1 MYO1E NAA35 IARS2 EIF4A1 HADHA ATP2A2 CAP1 | 4.87e-06 | 288 | 191 | 10 | 38496616 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DYNC2H1 TM9SF1 PSMB2 NOC3L DNAH2 ELP1 URB2 XPO1 NCLN ACSL3 NAA35 BAIAP2L1 EIF4A1 EIF2B5 HADHA PRKDC ATP2A2 DYNC1H1 | 5.09e-06 | 942 | 191 | 18 | 31073040 |
| Pubmed | 5.61e-06 | 7 | 191 | 3 | 9256245 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL30 HSP90B1 MYO1E MYO10 ANXA2 ANXA2P2 NOC3L APOB DDX50 EIF4A1 CHD5 USP7 HADHA PRKDC IK ATP2A2 CPSF3 DYNC1H1 | 5.63e-06 | 949 | 191 | 18 | 36574265 |
| Pubmed | 6.03e-06 | 47 | 191 | 5 | 8812413 | ||
| Pubmed | RPL30 HSP90B1 ANXA2 PSMB2 STK38 THUMPD1 CHD8 CHD2 TRMT10C DDX50 EIF4A1 CHD5 RABGAP1L MACF1 HADHA PRKDC MTREX STK38L FBXO21 DYNC1H1 | 6.27e-06 | 1153 | 191 | 20 | 29845934 | |
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 6.28e-06 | 82 | 191 | 6 | 30274258 | |
| Pubmed | RPL30 HSP90B1 MYO1E ELP1 NCLN SUCLA2 RAD50 TRMT10C EIF4A1 EIF2B5 MACF1 PRKDC ATP2A2 DYNC1H1 | 6.72e-06 | 601 | 191 | 14 | 33658012 | |
| Pubmed | 7.16e-06 | 237 | 191 | 9 | 29564676 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIS18BP1 OGT ERCC6 CHD8 CHD2 SIN3A FSIP2 GTF2E1 MORF4L1 CHD5 NIP7 USP7 WDR12 KDM4B | 7.66e-06 | 608 | 191 | 14 | 36089195 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MGAM COL6A3 ANXA2 ANXA2P2 PSMB2 APEH LAMP2 APOB ACE2 QSOX1 SERPINA4 ATP6V0D1 ARSB ATP8A1 PTPRG BAIAP2L1 PRKACB DYNC1H1 CAP1 | 7.80e-06 | 1070 | 191 | 19 | 23533145 |
| Pubmed | TCEA1 CUL2 HSP90B1 XPO1 SUCLA2 ACSL3 IARS2 TRMT10C EIF4A1 EIF5 HADHA PRKDC PGP HARS1 FH ATP2A2 DYNC1H1 | 7.93e-06 | 878 | 191 | 17 | 37223481 | |
| Pubmed | 8.95e-06 | 8 | 191 | 3 | 24469044 | ||
| Pubmed | 9.04e-06 | 244 | 191 | 9 | 28902428 | ||
| Pubmed | RPAP3 PSMB2 APEH CHD8 XPO1 SUCLA2 RAD50 UFD1 HADHA PRKDC PGP FH DYNC1H1 | 9.07e-06 | 534 | 191 | 13 | 35032548 | |
| Pubmed | HSP90B1 HK1 MYO1E ANXA2 NCLN ACSL3 IARS2 HADHA PRKDC DYNC1H1 | 9.81e-06 | 312 | 191 | 10 | 37120454 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 9.84e-06 | 134 | 191 | 7 | 25452129 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | SETD1A MYO1E TENT4A PSMB2 IARS2 ATP6V0D1 DDX50 HADHA IK CPSF3 | 1.01e-05 | 313 | 191 | 10 | 38270169 |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.01e-05 | 89 | 191 | 6 | 27034005 | |
| Pubmed | TCEA1 RPAP3 PSMB2 SIN3A XPO1 ACSL3 DDX50 RABGAP1L EIF5 USP7 PRKDC IK ATP2A2 | 1.17e-05 | 547 | 191 | 13 | 37267103 | |
| Pubmed | SETD1A RAPGEF6 OGT RPAP3 ANXA2 CHD8 SIN3A RAD50 PDCD5 USP7 PRKDC IK DYNC1H1 | 1.22e-05 | 549 | 191 | 13 | 38280479 | |
| Pubmed | HSP90B1 ELP1 SIN3A XPO1 RAD50 USP7 WDR12 HADHA PRKDC MTREX ATP2A2 CPSF3 DYNC1H1 CAP1 | 1.31e-05 | 638 | 191 | 14 | 33239621 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.33e-05 | 256 | 191 | 9 | 35777956 | |
| Pubmed | CUL2 SETD1A OGT PSMB2 NOC3L CHD8 SIN3A MDM2 RAD50 KAT2B RESF1 DDX50 MORF4L1 PDCD5 CHD5 NIP7 ARID5B USP7 HADHA ATP2A2 TAF1L DYNC1H1 | 1.37e-05 | 1429 | 191 | 22 | 35140242 | |
| Pubmed | 1.38e-05 | 94 | 191 | 6 | 36584595 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | CACNA1A PITPNM2 CACNA1E HSP90B1 DOCK11 ADGRB3 CHD8 PHKB NAA35 EIF5 PLCB1 RAPGEF2 | 1.40e-05 | 475 | 191 | 12 | 31040226 |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.41e-05 | 258 | 191 | 9 | 21081666 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.44e-05 | 197 | 191 | 8 | 20811636 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | RPL30 HSP90B1 ANXA2 STK38 PITPNM1 FSIP2 TRMT10C ATP6V0D1 EIF4A1 PDCD5 HADHA DYNC1H1 CAP1 | 1.44e-05 | 558 | 191 | 13 | 35063084 |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.45e-05 | 259 | 191 | 9 | 30404004 | |
| Interaction | SIRT7 interactions | RPL30 HK1 PHRF1 NOC3L ELP1 CHD8 CHD2 URB2 XPO1 MDM2 XAB2 RAD50 ACSL3 NEFL KAT2B IARS2 EIF4A1 USP7 MACF1 WDR12 HADHA PRKDC MTREX IK FH ATP2A2 CPSF3 DYNC1H1 CAP1 | 7.52e-11 | 744 | 189 | 29 | int:SIRT7 |
| Interaction | CIT interactions | RPL30 HSP90B1 MYO1E RPAP3 DYNC2H1 ANXA2 ANXA2P2 NOC3L CHD8 CHD2 APOB SIN3A PLXND1 XPO1 ZZEF1 XAB2 ACSL3 ACE2 NEFL TRMT10C DDX50 PTCD1 EIF4A1 NIP7 HASPIN MACF1 WDR12 HADHA PRKDC HARS1 MTREX IK FBXO21 ATP2A2 DYNC1H1 DYRK3 | 6.46e-08 | 1450 | 189 | 36 | int:CIT |
| Interaction | HSP90AA1 interactions | CUL2 RPL30 COL6A3 HSP90B1 FLT3 OGT RPAP3 STK38 APOB NDN BCL2 SIN3A PPARA XPO1 KATNA1 MDM2 RGS7 RAD50 ACE2 IARS2 RGS6 FBH1 PRKAA2 PRKACB HADHA PRKDC MTREX ZC3H7B STK38L DYNC1H1 CAP1 | 7.87e-07 | 1263 | 189 | 31 | int:HSP90AA1 |
| Interaction | TRIM33 interactions | MAGEA9 COL6A3 HK1 RPAP3 RBL2 ANXA2 ANXA2P2 ELP1 LAMP2 XPO1 RAD50 IARS2 RESF1 USP7 HADHA PRKDC MTREX | 1.37e-06 | 453 | 189 | 17 | int:TRIM33 |
| Interaction | C9orf78 interactions | CUL2 HK1 NRDC ELP1 SIN3A XPO1 XAB2 RAD50 ACSL3 INTS10 TRMT10C POLR3B ATP6V0D1 BAIAP2L1 EIF2B5 HADHA HARS1 MTREX IK DYNC1H1 | 1.63e-06 | 620 | 189 | 20 | int:C9orf78 |
| Interaction | BIRC3 interactions | RPL30 HSP90B1 HK1 DYNC2H1 ANXA2 PSMB2 APOB URB2 XPO1 NCLN SUCLA2 RAD50 ACSL3 IARS2 TRMT10C ATP6V0D1 DDX50 EIF4A1 EIF5 USP7 WDR12 HADHA PRKDC HARS1 MTREX IK FH ATP2A2 CPSF3 DYNC1H1 CAP1 | 2.48e-06 | 1334 | 189 | 31 | int:BIRC3 |
| Interaction | BRCA2 interactions | SHLD2 MAGEA9 HSP90B1 FLT3 ERCC6 BCL2 XPO1 MDM2 F8 XAB2 RAD50 KAT2B FBH1 MORF4L1 DYNC1H1 | 3.62e-06 | 384 | 189 | 15 | int:BRCA2 |
| Interaction | AURKB interactions | MAGEA9 HSP90B1 OGT MYO1E RPAP3 ANXA2 TBC1D2B SIN3A XPO1 MDM2 ZZEF1 RAD50 ACSL3 PHKB DDX50 EIF4A1 HASPIN MACF1 PRKDC ATP2A2 DYNC1H1 | 1.00e-05 | 761 | 189 | 21 | int:AURKB |
| Interaction | XRCC4 interactions | 1.22e-05 | 114 | 189 | 8 | int:XRCC4 | |
| Interaction | PRC1 interactions | CUL2 MAGEA9 HSP90B1 OGT MYO1E ANXA2 ANXA2P2 NOC3L URB2 ZZEF1 ACSL3 NEFL ATP6V0D1 DDX50 EIF4A1 CHD5 NIP7 HASPIN WDR12 HADHA PRKDC IK FBXO21 DYNC1H1 | 1.47e-05 | 973 | 189 | 24 | int:PRC1 |
| Interaction | EP300 interactions | TCEA1 SETD1A GCFC2 HK1 NRDC TENT4A RPAP3 ANXA2 ELP1 LAMP2 SIN3A PPARA XPO1 NCLN MDM2 XAB2 RAD50 ACSL3 KAT2B DDX50 MORF4L1 UFD1 USP7 HADHA PRKDC MTREX IK IL1A ATP2A2 CPSF3 | 1.82e-05 | 1401 | 189 | 30 | int:EP300 |
| Interaction | CACNA1C interactions | 2.27e-05 | 61 | 189 | 6 | int:CACNA1C | |
| Interaction | AGR2 interactions | HSP90B1 HK1 DYNC2H1 ANXA2 PSMB2 STK38 AP1M2 CHD8 ZZEF1 NAA35 IARS2 EIF4A1 UFD1 USP7 MACF1 PCNX1 HADHA PRKDC HARS1 FH ATP2A2 DYNC1H1 CAP1 | 2.30e-05 | 934 | 189 | 23 | int:AGR2 |
| Interaction | EED interactions | TCEA1 CUL2 RPL30 HSP90B1 OGT MYO1E VPS13C NOC3L STK38 ELP1 CHD2 SIN3A XPO1 MDM2 XAB2 RAD50 ATP6V0D1 DDX50 EIF4A1 NIP7 USP7 MACF1 WDR12 HADHA PRKDC MTREX IK ATP2A2 CPSF3 DYNC1H1 | 3.25e-05 | 1445 | 189 | 30 | int:EED |
| Interaction | SP1 interactions | HSP90B1 MIS18BP1 OGT MYO1E TNFSF10 ANXA2 SIN3A MDM2 KAT2B USP7 PRKDC MTREX DYNC1H1 | 4.29e-05 | 365 | 189 | 13 | int:SP1 |
| Interaction | CDC34 interactions | CUL2 ELP1 PPARA XPO1 MDM2 RAD50 ACSL3 HADHA PRKDC ATP2A2 CPSF3 DYNC1H1 | 6.57e-05 | 328 | 189 | 12 | int:CDC34 |
| Interaction | GSK3B interactions | UBR1 HSP90B1 RAPGEF6 OGT HK1 ANXA2 APEH XPO1 MDM2 ACSL3 IARS2 BAIAP2L1 PRKAA2 EIF2B5 PRKACB USP7 MACF1 HADHA PRKDC PICK1 CAP1 | 6.88e-05 | 868 | 189 | 21 | int:GSK3B |
| Interaction | DSCR9 interactions | 7.57e-05 | 147 | 189 | 8 | int:DSCR9 | |
| Interaction | HDAC4 interactions | CACNA1A PITPNM2 CACNA1E RPL30 HSP90B1 LZTR1 TNFSF10 DOCK11 ADGRB3 APEH CHD8 SIN3A PHKB NAA35 TIAM1 EIF5 PLCB1 RAPGEF2 PICK1 | 7.68e-05 | 744 | 189 | 19 | int:HDAC4 |
| Interaction | TSN interactions | 8.05e-05 | 110 | 189 | 7 | int:TSN | |
| Interaction | PRKCD interactions | LAMP2 PPARA OPRD1 PTPRA TIAM1 PLCB1 MACF1 CARD11 PRKDC DYNC1H1 | 8.70e-05 | 238 | 189 | 10 | int:PRKCD |
| Interaction | KMT2E interactions | 9.39e-05 | 49 | 189 | 5 | int:KMT2E | |
| Interaction | PFN1 interactions | DOCK4 RAPGEF6 ANXA2 VPS13C TBC1D2B ELP1 NBEA NDN ACE2 ATP8A1 BAIAP2L1 CHD5 RABGAP1L MACF1 CAP1 | 9.59e-05 | 509 | 189 | 15 | int:PFN1 |
| Interaction | DPP4 interactions | CUL2 HSP90B1 APOB MDM2 ACSL3 TRMT10C PTPRG BAIAP2L1 PLCB1 CARD11 HADHA PRKDC ATP2A2 DYNC1H1 | 1.00e-04 | 453 | 189 | 14 | int:DPP4 |
| Interaction | CAVIN1 interactions | OGT HK1 ERCC6 MYO1E MYO10 ZZEF1 ACE2 TRMT10C ARSB RABGAP1L CFAP57 | 1.03e-04 | 292 | 189 | 11 | int:CAVIN1 |
| Interaction | TRIM28 interactions | CUL2 SETD1A MAGEA9 OGT HK1 ELP1 THUMPD1 NDN SIN3A URB2 ZNF317 MDM2 SUCLA2 RAD50 ACE2 IARS2 POLR3B EIF4A1 NIP7 EIF5 PRKACB ZNF616 HADHA PRKDC MTREX IK ZC3H7B DNAH8 DYNC1H1 | 1.16e-04 | 1474 | 189 | 29 | int:TRIM28 |
| Interaction | SKI interactions | 1.37e-04 | 160 | 189 | 8 | int:SKI | |
| Interaction | RNF181 interactions | 1.37e-04 | 160 | 189 | 8 | int:RNF181 | |
| Interaction | KIF20A interactions | MIS18BP1 MYO1E DYNC2H1 ANXA2 ANXA2P2 INPP5B NOC3L CHD8 CHD2 APOB XPO1 ACE2 NEFL DDX50 EIF4A1 RABGAP1L NIP7 EIF2B5 MACF1 HADHA PRKDC GALNT6 IK | 1.40e-04 | 1052 | 189 | 23 | int:KIF20A |
| Interaction | GAN interactions | COL6A3 DYNC2H1 STK38 ZZEF1 NEFL EIF4A1 PLCB1 ZNF616 CFAP44 DNAH8 | 1.44e-04 | 253 | 189 | 10 | int:GAN |
| Interaction | SNCA interactions | CUL2 HK1 ANXA2 VPS13C STK38 NBEA LAMP2 SIN3A XPO1 RAD50 ACSL3 KAT2B USP7 PLCB1 MACF1 MTREX DYNC1H1 CAP1 | 1.45e-04 | 716 | 189 | 18 | int:SNCA |
| Interaction | SAP25 interactions | 1.48e-04 | 29 | 189 | 4 | int:SAP25 | |
| Interaction | KAT5 interactions | RPL30 OGT STK38 MDM2 RAD50 MORF4L1 PDCD5 USP7 PRKDC IK IL1A PICK1 | 1.50e-04 | 358 | 189 | 12 | int:KAT5 |
| Interaction | PEPD interactions | 1.59e-04 | 86 | 189 | 6 | int:PEPD | |
| Interaction | AR interactions | TCEA1 CUL2 OGT VPS13C PSMB2 AP1M2 CHD8 SIN3A XPO1 MDM2 XAB2 RAD50 ACSL3 NEFL KAT2B EIF4A1 ARID5B USP7 PRKDC MTREX IK DYNC1H1 | 1.61e-04 | 992 | 189 | 22 | int:AR |
| Interaction | MDM2 interactions | HSP90B1 ERCC6 RBL2 LAMP2 APOB NDN XPO1 MDM2 RAD50 ACE2 KAT2B RESF1 BAIAP2L1 PDCD5 USP7 MTREX ATP2A2 | 1.62e-04 | 658 | 189 | 17 | int:MDM2 |
| Interaction | RANBP2 interactions | CUL2 IFT140 NDN XPO1 MDM2 LGSN RAD50 ACE2 NAA35 PRKACB PRKDC IK | 1.62e-04 | 361 | 189 | 12 | int:RANBP2 |
| Interaction | AGAP2 interactions | CACNA1E ANXA2 NBEA PITPNM1 NEFL PRKACB MACF1 RAPGEF2 DYNC1H1 | 1.69e-04 | 210 | 189 | 9 | int:AGAP2 |
| Interaction | ANXA2P2 interactions | 1.78e-04 | 56 | 189 | 5 | int:ANXA2P2 | |
| Interaction | MAP1B interactions | CACNA1A HSP90B1 HK1 MYO1E PSMB2 STK38 APEH SIN3A XPO1 TRMT10C EIF4A1 HADHA PRKDC ATP2A2 DYNC1H1 | 1.79e-04 | 539 | 189 | 15 | int:MAP1B |
| Interaction | FBXW7 interactions | RPL30 HSP90B1 MYO1E ANXA2 PSMB2 STK38 ELP1 SIN3A XPO1 NCLN SUCLA2 RAD50 GTF2E1 IARS2 TRMT10C EIF4A1 UFD1 NIP7 EIF2B5 MACF1 HADHA PRKDC ATP2A2 CPSF3 DYNC1H1 | 1.82e-04 | 1215 | 189 | 25 | int:FBXW7 |
| Interaction | LPIN1 interactions | 1.93e-04 | 31 | 189 | 4 | int:LPIN1 | |
| Interaction | CEBPB interactions | TCEA1 RPL30 HSP90B1 HK1 ANXA2 ELP1 APEH SIN3A XPO1 MDM2 XAB2 RAD50 KAT2B TRMT10C ATP6V0D1 DDX50 EIF4A1 PDCD5 EIF5 USP7 HADHA PRKDC HARS1 MTREX IK FH DYNC1H1 CAP1 | 1.93e-04 | 1443 | 189 | 28 | int:CEBPB |
| Interaction | BCL2L14 interactions | 1.98e-04 | 127 | 189 | 7 | int:BCL2L14 | |
| Interaction | EFTUD2 interactions | RPL30 HSP90B1 OGT MYO1E RPAP3 ANXA2 PSMB2 ELP1 SIN3A MDM2 XAB2 RAD50 ACE2 GTF2E1 TRMT10C BAIAP2L1 MORF4L1 EIF4A1 UFD1 NIP7 USP7 MACF1 HADHA PRKDC HARS1 MTREX IK DYNC1H1 | 2.07e-04 | 1449 | 189 | 28 | int:EFTUD2 |
| Interaction | TPTE interactions | 2.18e-04 | 129 | 189 | 7 | int:TPTE | |
| Interaction | POLR1G interactions | OGT RPAP3 NOC3L CHD8 CHD2 URB2 XPO1 RAD50 GTF2E1 POLR3B DDX50 USP7 IK ATP2A2 | 2.21e-04 | 489 | 189 | 14 | int:POLR1G |
| Interaction | HTT interactions | CUL2 HSP90B1 OGT HK1 PSMB2 ELP1 LAMP2 SIN3A CPT1B SUCLA2 NEFL KAT2B ATP6V0D1 ATP8A1 UFD1 EIF5 PRKACB HADHA RAPGEF2 ATP2A2 DYNC1H1 | 2.36e-04 | 949 | 189 | 21 | int:HTT |
| Interaction | H3-3A interactions | SETD1A OGT ERCC6 CHD8 CHD2 SIN3A RAD50 GTF2E1 KAT2B TIAM1 MORF4L1 CHD5 NIP7 EIF5 USP7 PRKDC FH KDM4B | 2.52e-04 | 749 | 189 | 18 | int:H3-3A |
| Interaction | CSNK2A1 interactions | SETD1A HSP90B1 GCFC2 OGT RBL2 PHRF1 SIN3A URB2 XPO1 CAV2 MDM2 KAT2B POLR3B EIF2B5 EIF5 PRKACB USP7 MACF1 WDR12 PRKDC MTREX | 2.61e-04 | 956 | 189 | 21 | int:CSNK2A1 |
| Interaction | MYO7B interactions | 2.61e-04 | 3 | 189 | 2 | int:MYO7B | |
| Interaction | KCTD13 interactions | CACNA1A PITPNM2 RPL30 HSP90B1 OGT HK1 NRDC MYO1E ANXA2 ELP1 NBEA XPO1 SUCLA2 PITPNM1 PHKB NEFL ATP6V0D1 PTPRA ATP8A1 USP7 MACF1 HADHA RAPGEF2 FH ATP2A2 DYNC1H1 CAP1 | 2.62e-04 | 1394 | 189 | 27 | int:KCTD13 |
| Interaction | VAPA interactions | PITPNM2 HSP90B1 VPS13C LAMP2 SIN3A CAV2 NCLN OPRD1 OPRK1 PITPNM1 ADGRG7 ATP6V0D1 MORF4L1 USP40 EIF5 PRKACB ATP2A2 | 2.64e-04 | 686 | 189 | 17 | int:VAPA |
| Interaction | WDR5 interactions | SETD1A RPL30 HSP90B1 FLT3 OGT MYO1E CHD8 SIN3A XPO1 MDM2 ACSL3 QSOX1 KAT2B EIF2B5 EIF5 USP7 MACF1 WDR12 PRKDC HARS1 ATP2A2 DYNC1H1 KDM4B | 2.71e-04 | 1101 | 189 | 23 | int:WDR5 |
| Interaction | ERCC6 interactions | 2.74e-04 | 224 | 189 | 9 | int:ERCC6 | |
| Interaction | UFL1 interactions | RPL30 HSP90B1 GCFC2 OGT ANXA2P2 PSMB2 STK38 XPO1 NCLN ACSL3 IARS2 TRMT10C DDX50 EIF4A1 PRKAA2 PRKDC CFAP57 MTREX IK STK38L ATP2A2 CPSF3 | 2.77e-04 | 1031 | 189 | 22 | int:UFL1 |
| Interaction | ARFGAP1 interactions | 2.88e-04 | 135 | 189 | 7 | int:ARFGAP1 | |
| Interaction | WWOX interactions | RPL30 OGT RPAP3 ANXA2 LAMP2 NDN XPO1 NCLN MDM2 XAB2 ACSL3 HADHA RAPGEF2 IK ATP2A2 CPSF3 | 2.90e-04 | 627 | 189 | 16 | int:WWOX |
| Interaction | HNRNPU interactions | CUL2 RPL30 HSP90B1 ERCC6 NOC3L ELP1 LAMP2 NDN MDM2 ACE2 SLC25A32 KAT2B DDX50 BAIAP2L1 PTCD1 MORF4L1 NIP7 HADHA MTREX IK DYNC1H1 KDM4B | 2.92e-04 | 1035 | 189 | 22 | int:HNRNPU |
| Interaction | YJU2B interactions | 3.11e-04 | 63 | 189 | 5 | int:YJU2B | |
| Interaction | FOXO4 interactions | 3.13e-04 | 35 | 189 | 4 | int:FOXO4 | |
| Interaction | RPUSD2 interactions | 3.13e-04 | 35 | 189 | 4 | int:RPUSD2 | |
| Interaction | DDX5 interactions | TCEA1 CUL2 SETD1A OGT ERCC6 NDN XPO1 MDM2 RAD50 ACE2 EIF4A1 PRKACB USP7 PRKDC MTREX | 3.14e-04 | 568 | 189 | 15 | int:DDX5 |
| Interaction | H3C1 interactions | SETD1A ERCC6 DYNC2H1 NOC3L DNAH2 CHD8 SIN3A ZZEF1 RAD50 ACE2 GTF2E1 KAT2B NIP7 HASPIN USP7 HADHA PRKDC IK DNAH8 DYNC1H1 | 3.21e-04 | 901 | 189 | 20 | int:H3C1 |
| Interaction | BTG3 interactions | 3.24e-04 | 98 | 189 | 6 | int:BTG3 | |
| Interaction | HNRNPC interactions | CUL2 RPL30 OGT ANXA2 ANXA2P2 XPO1 F8 XAB2 ACE2 PHKB DDX50 PTCD1 USP7 PRKDC MTREX CAP1 | 3.28e-04 | 634 | 189 | 16 | int:HNRNPC |
| Interaction | RNF126 interactions | 3.29e-04 | 138 | 189 | 7 | int:RNF126 | |
| Interaction | G3BP1 interactions | TCEA1 RPL30 FLT3 OGT LAMP2 NDN XPO1 ACE2 TRMT10C DDX50 EIF4A1 PRKAA2 MACF1 IK ZC3H7B ATP2A2 CPSF3 DYNC1H1 CAP1 | 3.36e-04 | 835 | 189 | 19 | int:G3BP1 |
| Interaction | SLX4 interactions | HSP90B1 MIS18BP1 OGT ERCC6 ANXA2 CHD8 XAB2 RAD50 SDR9C7 RESF1 EIF4A1 PRKDC IK ATP2A2 DYNC1H1 | 3.38e-04 | 572 | 189 | 15 | int:SLX4 |
| Interaction | CWC27 interactions | 3.61e-04 | 100 | 189 | 6 | int:CWC27 | |
| Interaction | AURKAIP1 interactions | NRDC NOC3L IARS2 TRMT10C DDX50 PTCD1 NIP7 HADHA ATP2A2 TAF1L | 3.63e-04 | 284 | 189 | 10 | int:AURKAIP1 |
| Interaction | NECAB2 interactions | 3.81e-04 | 101 | 189 | 6 | int:NECAB2 | |
| Interaction | ASXL1 interactions | 3.83e-04 | 286 | 189 | 10 | int:ASXL1 | |
| Interaction | CCND1 interactions | OGT RBL2 XPO1 MDM2 KAT2B BAIAP2L1 ARID5B CARD11 HADHA DYNC1H1 | 3.83e-04 | 286 | 189 | 10 | int:CCND1 |
| Interaction | SUZ12 interactions | SETD1A MAGEA9 FLT3 MYO1E APEH CHD8 CHD2 SIN3A MDM2 XAB2 NEFL UFD1 USP7 IL1A ATP2A2 DYNC1H1 | 3.89e-04 | 644 | 189 | 16 | int:SUZ12 |
| Interaction | VCP interactions | CUL2 RPL30 HSP90B1 HK1 ERCC6 ANXA2 PSMB2 NBEA LAMP2 APOB CAV2 MDM2 RAD50 ACSL3 ACE2 PTPRA BAIAP2L1 IFT88 MORF4L1 EIF4A1 UFD1 USP7 HADHA PRKDC ATP2A2 DYNC1H1 CAP1 | 4.14e-04 | 1435 | 189 | 27 | int:VCP |
| Interaction | PSKH2 interactions | 4.15e-04 | 67 | 189 | 5 | int:PSKH2 | |
| Cytoband | 8q11.2 | 1.03e-04 | 4 | 191 | 2 | 8q11.2 | |
| GeneFamily | Dyneins, axonemal | 2.40e-04 | 17 | 132 | 3 | 536 | |
| GeneFamily | Opioid receptors | 3.14e-04 | 4 | 132 | 2 | 245 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 7.78e-04 | 6 | 132 | 2 | 1151 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.55e-03 | 115 | 132 | 5 | 769 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | UBR1 RPL30 RAPGEF6 MIS18BP1 OGT NRDC DOCK11 RBL2 VPS13C TBC1D2B ELP1 CHD2 BCL2 SIN3A XPO1 KAT2B PTPRA RESF1 ATP8A1 RABGAP1L EIF5 PRKACB MACF1 PCNX1 CARD11 IK DYNC1H1 CAP1 | 4.09e-06 | 1492 | 191 | 28 | M40023 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | TCEA1 MIS18BP1 BCL2 XPO1 CAV2 ZNF317 SUCLA2 ACSL3 PLCB1 ZNF616 HARS1 IK FH ETFRF1 | 5.76e-06 | 448 | 191 | 14 | MM1044 |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 1.71e-05 | 200 | 191 | 9 | M8032 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | TCEA1 MIS18BP1 BCL2 XPO1 CAV2 ZNF317 SUCLA2 ACSL3 PLCB1 HARS1 IK FH ETFRF1 | 1.95e-05 | 434 | 191 | 13 | M15150 |
| Coexpression | GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 2.97e-05 | 165 | 191 | 8 | M8992 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D4 | 4.62e-05 | 54 | 191 | 5 | M15468 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 CUL2 OGT MYO10 XPO1 CAV2 ZZEF1 RGS7 ACSL3 PTPRA TIAM1 RABGAP1L ARID5B PRKACB USP7 MACF1 MTREX RAPGEF2 | 5.90e-05 | 856 | 191 | 18 | M4500 |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_DN | 6.43e-05 | 184 | 191 | 8 | M6739 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | FLT3 RPAP3 RBL2 ANXA2 NOC3L THUMPD1 LAMP2 XPO1 RGS7 ACSL3 PHKB SLC25A32 SIDT2 RABGAP1L PRKACB MACF1 PRKDC HARS1 RAPGEF2 ATP2A2 DYNC1H1 CAP1 | 8.15e-05 | 1215 | 191 | 22 | M41122 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | TCEA1 CUL2 HSP90B1 RAPGEF6 MIS18BP1 RPAP3 MYO10 VPS13C NOC3L XPO1 RAD50 TRMT10C RESF1 RABGAP1L MTREX | 9.99e-05 | 656 | 191 | 15 | M18979 |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP | 1.07e-04 | 198 | 191 | 8 | M6168 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN | 1.07e-04 | 198 | 191 | 8 | M5417 | |
| Coexpression | GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN | 1.11e-04 | 199 | 191 | 8 | M8444 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 1.15e-04 | 200 | 191 | 8 | M8491 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP | 1.15e-04 | 200 | 191 | 8 | M6158 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP | 1.15e-04 | 200 | 191 | 8 | M6418 | |
| Coexpression | GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN | 1.15e-04 | 200 | 191 | 8 | M4111 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | CUL2 MIS18BP1 ERCC6 RPAP3 NOC3L SIN3A URB2 RAD50 ACSL3 SLC25A32 NEK3 KAT2B IARS2 POLR3B IFT88 WDR12 PRKDC CFAP61 MTREX STK38L SMC1B | 7.12e-06 | 810 | 183 | 21 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | DOCK4 SETD1A MGAM MIS18BP1 DOCK11 MYO10 TM9SF1 CHD8 CHD2 SIN3A ACE2 NAA35 RESF1 ATP8A1 ARID5B USP40 USP7 ZNF616 PGP SMC1B | 2.24e-05 | 806 | 183 | 20 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | SETD1A MGAM DOCK11 TM9SF1 STK38 NBEA CHD2 ACE2 ARID5B USP7 ZNF616 | 3.76e-05 | 284 | 183 | 11 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | DOCK4 SETD1A MGAM MIS18BP1 DOCK11 STK38 CHD8 CHD2 ACE2 NEFL NAA35 RESF1 ATP8A1 PTPRG ARID5B USP40 USP7 ZNF616 SMC1B | 6.97e-05 | 804 | 183 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| ToppCell | Ciliated-cil-3|World / Class top | DNAH3 DYNC2H1 DNAH2 CFAP100 IQCA1 CFAP206 CFAP61 CFAP57 CFAP44 DYRK3 | 1.14e-08 | 192 | 191 | 10 | 4989ebb8812b8af1870599acd932849122c05a29 |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | DNAH3 DNAH2 CFAP100 IQCA1 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 | 1.34e-07 | 189 | 191 | 9 | b55de812043b670cbde810d7d42f45909b6d66ef |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | DNAH3 DNAH2 CFAP100 IQCA1 TTC12 CFAP206 CFAP61 CFAP57 CFAP44 | 1.34e-07 | 189 | 191 | 9 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CACNA1A DYNC2H1 MYO10 VPS13C SLC30A8 NBEA MACF1 ATP2A2 DYNC1H1 | 1.75e-07 | 195 | 191 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.17e-07 | 200 | 191 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.63e-07 | 176 | 191 | 8 | b794275fdd757b8fa2108e3c867f23da2649146d | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.46e-06 | 186 | 191 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.58e-06 | 188 | 191 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.58e-06 | 188 | 191 | 8 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-06 | 189 | 191 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.92e-06 | 193 | 191 | 8 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-06 | 194 | 191 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 195 | 191 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.08e-06 | 195 | 191 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.24e-06 | 197 | 191 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.43e-06 | 147 | 191 | 7 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-06 | 160 | 191 | 7 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.25e-06 | 161 | 191 | 7 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | Mild/Remission-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.64e-06 | 166 | 191 | 7 | 03e1a369d8a83b814def07e29cabb023226b4828 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.59e-06 | 169 | 191 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-05 | 173 | 191 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 1.04e-05 | 174 | 191 | 7 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 178 | 191 | 7 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-05 | 181 | 191 | 7 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 181 | 191 | 7 | c1b1e62440805800a3a600b1ddd79be1c9762598 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 184 | 191 | 7 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 184 | 191 | 7 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-05 | 185 | 191 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-club_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-05 | 187 | 191 | 7 | a70aaae32426e9ddb1cbfbd0e0db24ccc96b9f40 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 187 | 191 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 187 | 191 | 7 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 187 | 191 | 7 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.71e-05 | 188 | 191 | 7 | e3e71c0f2e374330620cb4d27638953ffa9f5298 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 191 | 191 | 7 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-05 | 191 | 191 | 7 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 191 | 191 | 7 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.90e-05 | 191 | 191 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.90e-05 | 191 | 191 | 7 | 96483adb97c81208aa513782550acd8a08b63866 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 192 | 191 | 7 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.96e-05 | 192 | 191 | 7 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.03e-05 | 193 | 191 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-05 | 193 | 191 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.10e-05 | 194 | 191 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.10e-05 | 194 | 191 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.10e-05 | 194 | 191 | 7 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.17e-05 | 195 | 191 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-05 | 195 | 191 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-05 | 195 | 191 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.24e-05 | 196 | 191 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.24e-05 | 196 | 191 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 197 | 191 | 7 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.31e-05 | 197 | 191 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 197 | 191 | 7 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 197 | 191 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | URO-Myeloid-cDC2|URO / Disease, Lineage and Cell Type | 2.31e-05 | 197 | 191 | 7 | 7fee14356d7fba68a0515c8b9284568d14124b0a | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.39e-05 | 198 | 191 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 198 | 191 | 7 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | medial-Epithelial-Ciliated-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 199 | 191 | 7 | 526002f16bbf61cf086278d45a401cc0b0b757a8 | |
| ToppCell | medial-Epithelial-Ciliated|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 199 | 191 | 7 | a2daa42b100c422dc8c04fb7d2ebf54293eef574 | |
| ToppCell | medial-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-05 | 199 | 191 | 7 | c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.47e-05 | 199 | 191 | 7 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Sepsis-URO-Myeloid-cDC2|URO / Disease, condition lineage and cell class | 2.55e-05 | 200 | 191 | 7 | 4f696dc68a8ceec9a6e6293c6f6f878b321b0b6d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.55e-05 | 200 | 191 | 7 | 85c0f038bcfb42669dca2b80273b0f8a1421405e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 155 | 191 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-05 | 155 | 191 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-pDC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.01e-05 | 157 | 191 | 6 | 62f029831c420d3e9580822177545eb7fdf4d0a3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.44e-05 | 159 | 191 | 6 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.44e-05 | 159 | 191 | 6 | 141c3ed35c7d11fcaec4acd9cb37104cc259db25 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 6.67e-05 | 160 | 191 | 6 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.91e-05 | 161 | 191 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 7.15e-05 | 162 | 191 | 6 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 162 | 191 | 6 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.15e-05 | 162 | 191 | 6 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 164 | 191 | 6 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.18e-05 | 166 | 191 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.73e-05 | 168 | 191 | 6 | 8c95093b1ea45826f62893edd3c410fe53b563a4 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-G-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.73e-05 | 168 | 191 | 6 | b8c65542a0701ae31f49d332d87a64578e24b4e3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 9.63e-05 | 171 | 191 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.94e-05 | 172 | 191 | 6 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-04 | 175 | 191 | 6 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 177 | 191 | 6 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.16e-04 | 177 | 191 | 6 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | BAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 1.16e-04 | 177 | 191 | 6 | aa021f6d62e9d740c5ea499faaf875de835a2865 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 177 | 191 | 6 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.24e-04 | 179 | 191 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 180 | 191 | 6 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.31e-04 | 181 | 191 | 6 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-04 | 181 | 191 | 6 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.31e-04 | 181 | 191 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.35e-04 | 182 | 191 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 182 | 191 | 6 | 587636c0f127231de21acd8aa632b74ff22ca8c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 182 | 191 | 6 | adfadd7893e74b3002f13f00875e3667d3493e0c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.35e-04 | 182 | 191 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.39e-04 | 183 | 191 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 184 | 191 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 184 | 191 | 6 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 184 | 191 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.48e-04 | 185 | 191 | 6 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 185 | 191 | 6 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 185 | 191 | 6 | 110d5f02759c8235b14aea524ea47199696094ea | |
| Drug | Bay K 8644 | 4.69e-06 | 150 | 189 | 9 | CID000002303 | |
| Drug | Morphine | DNAH3 HSP90B1 TNFSF10 APOB BCL2 SIN3A OPRD1 OPRK1 RGS6 PDCD5 PLCB1 FH IL1A DYNC1H1 CAP1 | 5.15e-06 | 446 | 189 | 15 | ctd:D009020 |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.89e-06 | 196 | 189 | 10 | 7025_UP | |
| Drug | arabinosyladenine | CACNA1A CACNA1E MGAM AMPD1 HK1 RBL2 F8 OPRD1 OPRK1 GHSR IARS2 POLR3B PRKAA2 PRKACB CARD11 HARS1 IK IL1A ATP2A2 CPSF3 | 5.89e-06 | 762 | 189 | 20 | CID000000191 |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; HL60; HG-U133A | MIS18BP1 INPP5B SUCLA2 PDCD5 NIP7 PCNX1 PRKDC RAPGEF2 FH FBXO21 | 6.44e-06 | 198 | 189 | 10 | 1566_DN |
| Drug | Loperamide | 1.11e-05 | 6 | 189 | 3 | DB00836 | |
| Drug | CP-80 | 1.14e-05 | 36 | 189 | 5 | CID000452640 | |
| Drug | AC1Q6ZKG | 1.92e-05 | 7 | 189 | 3 | CID000031785 | |
| Drug | Tp w | 1.92e-05 | 7 | 189 | 3 | CID010364977 | |
| Drug | dioxadrol | 3.06e-05 | 8 | 189 | 3 | CID000066269 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.26e-05 | 191 | 189 | 9 | 4168_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; HL60; HG-U133A | 3.53e-05 | 193 | 189 | 9 | 1375_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 3.99e-05 | 196 | 189 | 9 | 3789_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 4.15e-05 | 197 | 189 | 9 | 6936_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.15e-05 | 197 | 189 | 9 | 5314_UP | |
| Drug | Zinc Sulfate | SHLD2 COL6A3 IFT140 OGT HK1 ANXA2 PSMB2 ATP13A5 BCL2 PPARA PLXND1 NCLN LGSN SIDT2 CHD5 ZC3H7B IL1A DYNC1H1 | 4.69e-05 | 739 | 189 | 18 | ctd:D019287 |
| Drug | Glucose | MGAM HSP90B1 OGT HK1 PSMB2 SLC30A8 ELP1 NBEA LAMP2 APOB BCL2 PPARA SUCLA2 RAD50 PHKB KAT2B IARS2 ATP6V0D1 BAIAP2L1 MORF4L1 AGTR1 PRKAA2 EIF5 PLCB1 PCNX1 MTREX KDM4B | 4.80e-05 | 1420 | 189 | 27 | ctd:D005947 |
| Drug | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester | 5.29e-05 | 116 | 189 | 7 | ctd:C070379 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 5.92e-05 | 160 | 189 | 8 | 6133_DN | |
| Drug | calcium citrate | 6.85e-05 | 2 | 189 | 2 | CID000013136 | |
| Drug | erinacine E | 6.85e-05 | 2 | 189 | 2 | CID005317180 | |
| Drug | Tb-FTP | 6.85e-05 | 2 | 189 | 2 | CID000196616 | |
| Drug | Dynorphin (1-11) | 6.85e-05 | 2 | 189 | 2 | CID003086114 | |
| Drug | (-)-EKC | 6.85e-05 | 2 | 189 | 2 | CID000042800 | |
| Drug | 2-aminooxazole | 6.85e-05 | 2 | 189 | 2 | CID000558521 | |
| Drug | MR-1353 | 6.85e-05 | 2 | 189 | 2 | CID000197198 | |
| Drug | trefentanil | 6.85e-05 | 2 | 189 | 2 | CID000060727 | |
| Drug | candesartan cilexetil | 8.06e-05 | 28 | 189 | 4 | ctd:C077793 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 8.49e-05 | 125 | 189 | 7 | CID000002603 | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 8.69e-05 | 169 | 189 | 8 | 3464_DN | |
| Drug | AC1L1IIA | 9.83e-05 | 172 | 189 | 8 | CID000004591 | |
| Drug | mg U | 1.06e-04 | 30 | 189 | 4 | CID000445508 | |
| Drug | Tedam | 1.17e-04 | 12 | 189 | 3 | CID000124900 | |
| Drug | Tedapge | 1.17e-04 | 12 | 189 | 3 | CID000146381 | |
| Drug | Dichlorvos | 1.19e-04 | 92 | 189 | 6 | ctd:D004006 | |
| Drug | purealin | 1.20e-04 | 58 | 189 | 5 | CID006419303 | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.30e-04 | 179 | 189 | 8 | 4585_DN | |
| Drug | AC1MHEDK | 1.34e-04 | 94 | 189 | 6 | CID003002889 | |
| Drug | Nebeldose | 1.41e-04 | 60 | 189 | 5 | CID000165707 | |
| Drug | pantogab | CUL2 SHLD2 RPAP3 TBC1D2B QSOX1 NAA35 KAT2B BAIAP2L1 RNF141 RABGAP1L PRKAA2 PRKACB PGP FH ATP2A2 | 1.57e-04 | 601 | 189 | 15 | ctd:C016030 |
| Drug | nitrendipine | 1.69e-04 | 98 | 189 | 6 | CID000004507 | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.81e-04 | 188 | 189 | 8 | 3325_DN | |
| Drug | S-(-)-Etomoxir | 1.89e-04 | 100 | 189 | 6 | CID000060765 | |
| Drug | TDAM | 1.92e-04 | 14 | 189 | 3 | CID000124899 | |
| Drug | pyrrolidone | 1.97e-04 | 35 | 189 | 4 | CID000012025 | |
| Drug | morphine hydrochloride | CACNA1A CACNA1E TNFSF10 MDM2 ITGAX RGS7 OPRD1 OPRK1 NEFL RGS6 AGTR1 PRKACB UGT2B4 | 2.02e-04 | 481 | 189 | 13 | CID000004253 |
| Drug | TRK 820 | 2.05e-04 | 3 | 189 | 2 | ctd:C111212 | |
| Drug | Oxycodone | 2.05e-04 | 3 | 189 | 2 | DB00497 | |
| Drug | Hydromorphone | 2.05e-04 | 3 | 189 | 2 | DB00327 | |
| Drug | Codeine | 2.05e-04 | 3 | 189 | 2 | DB00318 | |
| Drug | Kdo2 | 2.05e-04 | 3 | 189 | 2 | CID000196322 | |
| Drug | Carfentanil | 2.05e-04 | 3 | 189 | 2 | DB01535 | |
| Drug | Morphine | 2.05e-04 | 3 | 189 | 2 | DB00295 | |
| Drug | Hydrocodone | 2.05e-04 | 3 | 189 | 2 | ctd:D006853 | |
| Drug | 3-Methylfentanyl | 2.05e-04 | 3 | 189 | 2 | DB01571 | |
| Drug | Heroin | 2.05e-04 | 3 | 189 | 2 | DB01452 | |
| Drug | 3-Methylthiofentanyl | 2.05e-04 | 3 | 189 | 2 | DB01439 | |
| Drug | morphine-7,8-oxide | 2.05e-04 | 3 | 189 | 2 | CID005491901 | |
| Drug | Levorphanol | 2.05e-04 | 3 | 189 | 2 | ctd:D007981 | |
| Drug | Levallorphan | 2.05e-04 | 3 | 189 | 2 | ctd:D007977 | |
| Drug | NSC11411 | 2.05e-04 | 3 | 189 | 2 | CID000408117 | |
| Drug | Buprenorphine | 2.05e-04 | 3 | 189 | 2 | DB00921 | |
| Drug | Levorphanol | 2.05e-04 | 3 | 189 | 2 | DB00854 | |
| Drug | Remifentanil | 2.05e-04 | 3 | 189 | 2 | DB00899 | |
| Drug | Nalbuphine | 2.05e-04 | 3 | 189 | 2 | DB00844 | |
| Drug | Fentanyl | 2.05e-04 | 3 | 189 | 2 | DB00813 | |
| Drug | Sufentanil | 2.05e-04 | 3 | 189 | 2 | DB00708 | |
| Drug | Ro 64-6198 | 2.05e-04 | 3 | 189 | 2 | CID009844019 | |
| Drug | Propoxyphene | 2.05e-04 | 3 | 189 | 2 | DB00647 | |
| Drug | Butorphanol | 2.05e-04 | 3 | 189 | 2 | DB00611 | |
| Drug | Butorphanol | 2.05e-04 | 3 | 189 | 2 | ctd:D002077 | |
| Drug | cyclorphan | 2.05e-04 | 3 | 189 | 2 | ctd:C084603 | |
| Drug | up hit | 2.05e-04 | 3 | 189 | 2 | CID000129713 | |
| Drug | lysocellin | 2.05e-04 | 3 | 189 | 2 | CID003036964 | |
| Drug | Alvimopan | 2.05e-04 | 3 | 189 | 2 | DB06274 | |
| Drug | dextrallorphan | 2.05e-04 | 3 | 189 | 2 | ctd:C044130 | |
| Drug | cloquintocet-mexyl | 2.05e-04 | 3 | 189 | 2 | CID000093528 | |
| Drug | 14-phenylpropoxymetopon | 2.05e-04 | 3 | 189 | 2 | ctd:C478565 | |
| Drug | qingre zaoshi liangxue fang | 2.05e-04 | 3 | 189 | 2 | ctd:C000594493 | |
| Drug | NSC612112 | 2.05e-04 | 3 | 189 | 2 | CID000356432 | |
| Drug | indolin-3-one | 2.05e-04 | 3 | 189 | 2 | CID000230915 | |
| Drug | naloxazine | 2.05e-04 | 3 | 189 | 2 | CID003081567 | |
| Drug | hydroxylamine sulfate | 2.05e-04 | 3 | 189 | 2 | CID000024846 | |
| Drug | 3,6-anhydro-D-galactose 2-sulfate | 2.06e-04 | 65 | 189 | 5 | CID000446806 | |
| Drug | prazosin | 2.17e-04 | 193 | 189 | 8 | CID000004893 | |
| Drug | dihydropyridine | 2.17e-04 | 193 | 189 | 8 | CID000104822 | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | 2.17e-04 | 193 | 189 | 8 | 1988_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.17e-04 | 193 | 189 | 8 | 1079_UP | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.17e-04 | 193 | 189 | 8 | 6809_UP | |
| Drug | Dethiocoenzyme A | 2.33e-04 | 147 | 189 | 7 | CID000003002 | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.33e-04 | 195 | 189 | 8 | 1521_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.33e-04 | 195 | 189 | 8 | 1505_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A | 2.33e-04 | 195 | 189 | 8 | 1984_DN | |
| Drug | gallopamil | 2.38e-04 | 67 | 189 | 5 | CID000001234 | |
| Drug | butamben | 2.38e-04 | 15 | 189 | 3 | CID000002482 | |
| Drug | iodophenyl | 2.38e-04 | 15 | 189 | 3 | CID000011575 | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 2.41e-04 | 196 | 189 | 8 | 6954_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.41e-04 | 196 | 189 | 8 | 990_UP | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.41e-04 | 196 | 189 | 8 | 2737_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.41e-04 | 196 | 189 | 8 | 2818_DN | |
| Disease | IGF-1 measurement | IFT140 TNFSF10 VPS13C AP1M2 ELP1 C6orf163 BCL2 PPARA OPRD1 GHSR VSTM4 RESF1 CFAP61 KDM4B | 2.76e-06 | 488 | 185 | 14 | EFO_0004627 |
| Disease | testosterone measurement | DOCK4 UBR1 NRDC TNFSF10 ANXA2 C3orf38 PSMB2 DNAH2 BCL2 SIN3A PPARA STARD6 GHSR KAT2B ATP6V0D1 RGS6 PTPRG BAIAP2L1 ARID5B USP7 UGT2B4 PLCB1 MACF1 | 5.48e-06 | 1275 | 185 | 23 | EFO_0004908 |
| Disease | migraine disorder | DOCK4 CACNA1A INPP5B C3orf38 NBEA SDR9C7 VSTM4 RABGAP1L MACF1 WDR12 DYRK3 | 1.72e-05 | 357 | 185 | 11 | MONDO_0005277 |
| Disease | neutrophil percentage of leukocytes | FLT3 BCL2 NCLN RAD50 VSTM4 BAIAP2L1 PTCD1 ARID5B PLCB1 PRKDC CFAP61 ZC3H7B IL1A KDM4B | 3.36e-05 | 610 | 185 | 14 | EFO_0007990 |
| Disease | priapism (biomarker_via_orthology) | 3.91e-05 | 2 | 185 | 2 | DOID:9286 (biomarker_via_orthology) | |
| Disease | lymphocyte percentage of leukocytes | FLT3 AP1M2 BCL2 NCLN VSTM4 BAIAP2L1 PTCD1 ARID5B PLCB1 CARD11 PRKDC CFAP61 ZC3H7B KDM4B | 8.46e-05 | 665 | 185 | 14 | EFO_0007993 |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.17e-04 | 3 | 185 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Intellectual Disability | CACNA1E SETD1A HK1 NBEA CHD8 SIN3A RGS7 ACE2 POLR3B MACF1 DYNC1H1 | 1.30e-04 | 447 | 185 | 11 | C3714756 |
| Disease | mean reticulocyte volume | SETD1A FLT3 HK1 NOC3L DNAH2 STK38 AP1M2 BCL2 URB2 XPO1 KAT2B PTPRA RESF1 PDCD5 SRL | 1.67e-04 | 799 | 185 | 15 | EFO_0010701 |
| Disease | Cardiomegaly | 1.69e-04 | 82 | 185 | 5 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.69e-04 | 82 | 185 | 5 | C1383860 | |
| Disease | Dystonia | 2.12e-04 | 86 | 185 | 5 | C0013421 | |
| Disease | migraine (implicated_via_orthology) | 2.33e-04 | 4 | 185 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_marker_for) | 2.54e-04 | 49 | 185 | 4 | DOID:9119 (is_marker_for) | |
| Disease | obsolete_red blood cell distribution width | FLT3 OGT HK1 TENT4A INPP5B AP1M2 APEH APOB ITGAX F8 INTS10 VSTM4 PTPRA RESF1 MORF4L1 EIF4A1 PDCD5 RABGAP1L GALNT6 ZC3H7B | 3.24e-04 | 1347 | 185 | 20 | EFO_0005192 |
| Disease | Mesenchymal Chondrosarcoma | 3.86e-04 | 5 | 185 | 2 | C0206637 | |
| Disease | hemoglobin A1 measurement | MGAM HK1 SLC30A8 BCL2 PLXND1 ITGAX VSTM4 PTPRA PDCD5 PLCB1 MACF1 | 4.71e-04 | 520 | 185 | 11 | EFO_0007629 |
| Disease | TEMPS-A questionnaire | 5.04e-04 | 25 | 185 | 3 | EFO_0004783 | |
| Disease | VACTERL association (implicated_via_orthology) | 5.77e-04 | 6 | 185 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 5.77e-04 | 6 | 185 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Streptozotocin Diabetes | 6.07e-04 | 108 | 185 | 5 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 6.07e-04 | 108 | 185 | 5 | C0011853 | |
| Disease | Alloxan Diabetes | 6.07e-04 | 108 | 185 | 5 | C0002152 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 7.09e-04 | 64 | 185 | 4 | DOID:224 (implicated_via_orthology) | |
| Disease | myocardial infarction (implicated_via_orthology) | 7.96e-04 | 66 | 185 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (is_implicated_in) | 8.69e-04 | 30 | 185 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | Severe Congenital Microcephaly | 9.58e-04 | 31 | 185 | 3 | C3853041 | |
| Disease | fear of minor pain measurement | 9.58e-04 | 31 | 185 | 3 | EFO_0008340 | |
| Disease | body weight | MGAM TENT4A VPS13C INPP5B C3orf38 ADGRB3 ATP13A5 CHD8 NDN BCL2 ZZEF1 GHSR ACSL3 PTPRG PDCD5 RABGAP1L PGP KDM4B | 1.02e-03 | 1261 | 185 | 18 | EFO_0004338 |
| Disease | platelet crit | DNAH3 FLT3 HK1 MYO1E NOC3L AP1M2 APOB BCL2 ITGAX VSTM4 PHKB ARID5B USP7 PLCB1 SPDYC | 1.03e-03 | 952 | 185 | 15 | EFO_0007985 |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.07e-03 | 8 | 185 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Microlissencephaly | 1.15e-03 | 33 | 185 | 3 | C1956147 | |
| Disease | Alzheimer's disease (is_marker_for) | 1.24e-03 | 257 | 185 | 7 | DOID:10652 (is_marker_for) | |
| Disease | underweight body mass index status | 1.37e-03 | 9 | 185 | 2 | EFO_0005936 | |
| Disease | age at menarche | FLT3 RPAP3 MYO10 C3orf38 DNAH2 CHD2 OPRK1 PTPRG PLCB1 CFAP61 KDM4B | 1.39e-03 | 594 | 185 | 11 | EFO_0004703 |
| Disease | Schizophrenia | DOCK4 SETD1A RAPGEF6 HK1 BCL2 PPARA PITPNM1 NEFL PTPRA UFD1 EIF5 PLCB1 ATP2A2 PICK1 | 1.42e-03 | 883 | 185 | 14 | C0036341 |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.63e-03 | 80 | 185 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Aortic Aneurysm, Abdominal | 1.70e-03 | 10 | 185 | 2 | C0162871 | |
| Disease | Prostatic Neoplasms | HSP90B1 TNFSF10 BCL2 PPARA XPO1 CAV2 MDM2 PRKACB USP7 PRKDC TAF1L | 1.84e-03 | 616 | 185 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | HSP90B1 TNFSF10 BCL2 PPARA XPO1 CAV2 MDM2 PRKACB USP7 PRKDC TAF1L | 1.84e-03 | 616 | 185 | 11 | C0376358 |
| Disease | Profound Mental Retardation | 1.87e-03 | 139 | 185 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.87e-03 | 139 | 185 | 5 | C0025363 | |
| Disease | Mental deficiency | 1.87e-03 | 139 | 185 | 5 | C0917816 | |
| Disease | lung cancer (is_marker_for) | 1.88e-03 | 39 | 185 | 3 | DOID:1324 (is_marker_for) | |
| Disease | urate measurement, bone density | ADGRB3 FSIP2 RGS6 PTPRG RABGAP1L ARID5B USP40 PRKACB PLCB1 PRKDC DNAH8 | 1.91e-03 | 619 | 185 | 11 | EFO_0003923, EFO_0004531 |
| Disease | mean platelet volume | PITPNM2 NRDC MYO1E DOCK11 STK38 BCL2 SIN3A PLXND1 OPRD1 ACSL3 PDCD5 USP7 PLCB1 STK38L PICK1 | 2.01e-03 | 1020 | 185 | 15 | EFO_0004584 |
| Disease | Malignant neoplasm of liver | 2.06e-03 | 142 | 185 | 5 | C0345904 | |
| Disease | stomach cancer (is_marker_for) | 2.06e-03 | 142 | 185 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Liver neoplasms | 2.06e-03 | 142 | 185 | 5 | C0023903 | |
| Disease | Jeune thoracic dystrophy | 2.07e-03 | 11 | 185 | 2 | C0265275 | |
| Disease | Macrocephaly | 2.07e-03 | 11 | 185 | 2 | C0221355 | |
| Disease | beta thalassemia (is_marker_for) | 2.07e-03 | 11 | 185 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Myoclonic Astatic Epilepsy | 2.07e-03 | 11 | 185 | 2 | C0393702 | |
| Disease | congestive heart failure (implicated_via_orthology) | 2.17e-03 | 41 | 185 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | hypothyroidism | 2.18e-03 | 284 | 185 | 7 | EFO_0004705 | |
| Disease | Charcot-Marie-Tooth disease | 2.33e-03 | 42 | 185 | 3 | cv:C0007959 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 2.48e-03 | 12 | 185 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | tryptophan betaine measurement | 2.48e-03 | 12 | 185 | 2 | EFO_0021017 | |
| Disease | Short Rib-Polydactyly Syndrome | 2.91e-03 | 13 | 185 | 2 | C0036996 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 3.18e-03 | 157 | 185 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Saldino-Noonan Syndrome | 3.39e-03 | 14 | 185 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 3.39e-03 | 14 | 185 | 2 | C0024507 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 3.39e-03 | 14 | 185 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | frontal fibrosing alopecia | 3.41e-03 | 48 | 185 | 3 | EFO_0009855 | |
| Disease | coronary artery disease (is_implicated_in) | 3.67e-03 | 100 | 185 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | eosinophil percentage of granulocytes | 3.69e-03 | 234 | 185 | 6 | EFO_0007996 | |
| Disease | Tourette syndrome | 3.83e-03 | 50 | 185 | 3 | EFO_0004895 | |
| Disease | Hypertriglyceridemia | 3.89e-03 | 15 | 185 | 2 | C0020557 | |
| Disease | Alzheimer disease, polygenic risk score | CUL2 CACNA1E ZZEF1 ITGAX FSIP2 RESF1 RNF141 HADHA RAPGEF2 KDM4B | 4.05e-03 | 586 | 185 | 10 | EFO_0030082, MONDO_0004975 |
| Disease | basophil count, eosinophil count | 4.26e-03 | 241 | 185 | 6 | EFO_0004842, EFO_0005090 | |
| Disease | Early Pregnancy Loss | 4.99e-03 | 109 | 185 | 4 | C3830362 | |
| Disease | Malignant mesothelioma | 4.99e-03 | 109 | 185 | 4 | C0345967 | |
| Disease | Spontaneous abortion | 4.99e-03 | 109 | 185 | 4 | C0000786 | |
| Disease | Miscarriage | 4.99e-03 | 109 | 185 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 4.99e-03 | 109 | 185 | 4 | C0000822 | |
| Disease | Lipidemias | 5.00e-03 | 17 | 185 | 2 | C1706412 | |
| Disease | phosphatidylcholine 40:6 measurement | 5.00e-03 | 17 | 185 | 2 | EFO_0010389 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 5.00e-03 | 17 | 185 | 2 | cv:C0270914 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 5.00e-03 | 17 | 185 | 2 | DOID:11984 (is_marker_for) | |
| Disease | bacteriemia | 5.00e-03 | 17 | 185 | 2 | EFO_0003033 | |
| Disease | Hyperlipidemia | 5.00e-03 | 17 | 185 | 2 | C0020473 | |
| Disease | clonal hematopoiesis mutation measurement | 5.01e-03 | 55 | 185 | 3 | EFO_0020949 | |
| Disease | cholesterol to total lipids in large HDL percentage | 5.01e-03 | 55 | 185 | 3 | EFO_0022234 | |
| Disease | Chronic Lymphocytic Leukemia | 5.01e-03 | 55 | 185 | 3 | C0023434 | |
| Disease | Myocardial Ischemia | 5.15e-03 | 176 | 185 | 5 | C0151744 | |
| Disease | essential hypertension (is_implicated_in) | 5.60e-03 | 18 | 185 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.79e-03 | 181 | 185 | 5 | DOID:684 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DIEQYQFIYKAMLSL | 1396 | P23470 | |
| TYCLEQLYLQKMKRT | 671 | Q14146 | |
| IMEYYRQSKAKKLQA | 1961 | O00555 | |
| LEKKLQYATNYFLMS | 81 | P41595 | |
| YFRIHINKYKMVETI | 1086 | Q8NHU2 | |
| EFQRYMRKKVFCLYL | 81 | Q4VNC0 | |
| YQRSYKREQMKIEAA | 1756 | Q9HCK8 | |
| KKIKANYVCLQERYM | 411 | Q8TC20 | |
| QVRYMKIIEKSGYQA | 391 | Q9Y6Q5 | |
| YELALKYLNIAFTMV | 1506 | Q15878 | |
| LIVRVELSQMQKKYY | 946 | Q8TDI0 | |
| ELSQMQKKYYKFILT | 951 | Q8TDI0 | |
| VYQTYVNAMNDKIRK | 281 | Q9UKF6 | |
| MKAVRNLLIYIFSTY | 1 | O60242 | |
| VKMSLQLYLVDNRSY | 451 | P54646 | |
| NSLVVIVIYFYMKLK | 46 | P30556 | |
| AMFYTNRVLKEYKDV | 161 | Q01518 | |
| QEINRVYKEMYKTDL | 141 | P07355 | |
| YRALCIREKYMQKSF | 141 | P23109 | |
| ELQETRMAFQKYINY | 281 | Q5TEZ5 | |
| TNFAVLMTFKKDYQY | 416 | Q96K78 | |
| FSREKMYLYNIQEKD | 256 | Q9NQ90 | |
| QEINRVYKEMYKTDL | 141 | A6NMY6 | |
| KRDEIKHVYMQQYLV | 1356 | Q96MT7 | |
| KHVYMQQYLVNRIKE | 1361 | Q96MT7 | |
| ALFMKQIYLQEYRAK | 181 | Q86XH1 | |
| QIYLQEYRAKQSKML | 186 | Q86XH1 | |
| LEVFLRAQKYTYLKM | 871 | Q03468 | |
| DYSIAQFKYLKNLLM | 831 | Q9Y2Q0 | |
| MLKEALYNIRQYEVF | 261 | Q8IYR0 | |
| LDIYYKTLDQAIMKF | 1121 | Q92878 | |
| AMYTYFQAKIRALKG | 726 | O00391 | |
| YAIYLCKRTMQNKAR | 131 | P49758 | |
| VLYKVGFFKRQYKEM | 1126 | P20702 | |
| YKNQVVYSTMLVFFK | 306 | Q9NVR2 | |
| FLTDMIIYQGQYKKA | 451 | Q9NVR2 | |
| FYDQLKQVMNAYRVK | 506 | Q969V3 | |
| RQYKGMFDTLVKIYK | 161 | Q9H2D1 | |
| KEYFNVMLGTQLLYK | 261 | Q9UBU8 | |
| NIYIKQIKTFAMKYS | 1011 | Q08999 | |
| QRAMQVYKYKEDVTD | 1016 | Q5HY64 | |
| NYVLYDQLKFKGNRM | 266 | O94952 | |
| NVKYNFMRIIKYEFI | 121 | P01583 | |
| LAVKKYFQRITLYLM | 141 | P01570 | |
| FEVLMQFLYTDKIKY | 521 | Q8N653 | |
| SYEKVINYLVMLNAR | 281 | P43362 | |
| EERKYMAINQKKAYI | 636 | Q6P0N0 | |
| YYVSKKLFMADLQRV | 781 | Q92831 | |
| EYEKYQELQLKSQRM | 791 | Q96MR6 | |
| DVTYHKNEMLQFKIY | 1041 | O43451 | |
| RYKEMVQKIVNSVYG | 5016 | Q5CZC0 | |
| LKYAYNISLKEVMQV | 581 | Q13144 | |
| LNRRYLSPKYIKMFV | 166 | P60842 | |
| MLQVFDLRKVLTTYY | 1686 | Q96RV3 | |
| KTKAVENYLIQMARY | 66 | O14737 | |
| YRKIVQRYYKQIQDM | 1831 | Q9Y4D7 | |
| FSYMKLTKALRYLQQ | 176 | A6NDG6 | |
| SYMIAFINEYLKKLS | 1096 | Q96JB1 | |
| KVFEDTYTYMKLNLN | 2296 | Q96JB1 | |
| DFYKRYKVLMRNLAL | 681 | Q9HD67 | |
| VANLVKAYVDKYRHM | 1616 | Q9P1Y6 | |
| YNIQKKAMTVGEYRR | 86 | O94953 | |
| ENRFYLKEVNISMYL | 291 | P13473 | |
| KMETNYQRFTIDKYL | 926 | O95163 | |
| VFTVRKKEEYKMALY | 1981 | P00451 | |
| LEALYFLRKYRAMKQ | 66 | Q6IPR1 | |
| QLYMIQKKSRNETYG | 21 | Q9BZ72 | |
| MIAAQLLAYYFTELK | 1 | P19367 | |
| YSYELQFLVKQMFKR | 226 | P51956 | |
| IVKDYELQLMTYKAF | 1346 | Q9UPN3 | |
| VRAAEFIKNYMKKYS | 341 | Q5XG87 | |
| LKKYEKEYQTMRESQ | 786 | Q5R372 | |
| RYTKMKTATNIYIFN | 76 | P41143 | |
| QYVERMKEKQDKIYF | 526 | P14625 | |
| YKKQFRYESQLQMVQ | 566 | P36888 | |
| MKGNVKSRLQIYYQE | 1036 | Q8NCM8 | |
| QLKEMKFTYLINYIQ | 4316 | P04114 | |
| AIYNNMKQFIRYLIS | 751 | P16615 | |
| DQFYRYKMPRLIAKV | 11 | P55010 | |
| KKLYHRYLMNEEQAV | 256 | Q8NFZ0 | |
| FLLIQSEKMKNDYIY | 416 | A0AVF1 | |
| QRNYSKAIKFYRMAL | 246 | Q13099 | |
| TEQYYAMKILDKQKV | 66 | P22694 | |
| DVKYMNATLKRYQTE | 111 | Q9UHR4 | |
| ITVTMKVFKRRYFYL | 181 | Q5JSL3 | |
| YLLMRNNFEYTKRKT | 1506 | Q5JSL3 | |
| LNFYKTELNKEEMYI | 1186 | Q8N1I0 | |
| EDYFRIYTDKLKNIM | 236 | Q8NEX9 | |
| LRYGKMLVQATKTIY | 2241 | Q8TD57 | |
| QALNCKFYKSMKIYV | 316 | P16383 | |
| KFYKSMKIYVENLID | 321 | P16383 | |
| ILYNIMSKKYRVAVF | 321 | Q92847 | |
| ILRVEMSALQKQYYK | 716 | O14647 | |
| YVQQVKYAMTRIKAA | 251 | P07954 | |
| MDSYKKIFYRRNLQA | 436 | Q8NCL4 | |
| VKLRFYYNTSEQNVM | 176 | Q5JPI3 | |
| RRNMYVNIAVNYLKK | 81 | P0C843 | |
| TLFQFNEMKKYIAYL | 2631 | P12111 | |
| NEMKKYIAYLVRQLD | 2636 | P12111 | |
| MYLKQILYLLEKFVA | 441 | A8MPP1 | |
| MDCLYRYLNTQFIKK | 101 | Q13617 | |
| VAKKYMKSRYEQVDL | 336 | Q9BQ39 | |
| SVAYAMRQYFLKVKN | 646 | Q9BYF1 | |
| YIKQKRQMFLLQYAL | 151 | Q494V2 | |
| DYQFDIYRLMKKENN | 716 | Q8TF76 | |
| YKNMYSTNIFTKRAI | 206 | P15848 | |
| YAMTIPFVRQQVYKK | 271 | P40939 | |
| EKDFQMLYAYDQLKI | 546 | P32019 | |
| ASYEFVQRLLKGYMK | 1381 | Q14204 | |
| MNKYLYSVKDTYLQQ | 36 | O75449 | |
| IKFLNRNAYIMIAIY | 566 | Q8NCS7 | |
| LFEISKYVMYKFLTV | 76 | P51636 | |
| RTYDKKAVDLYMLFN | 506 | Q9P225 | |
| ARYLAMNKLTNIKRY | 136 | P12081 | |
| SRQKEIYIMAANYLQ | 1241 | Q96RY7 | |
| VELLTFQERYYKMKE | 171 | Q9BXL7 | |
| VYDHKLRQYVALKMV | 226 | O43781 | |
| YYRMELLAKEFQDKT | 201 | Q92523 | |
| LYCYMRQADKVQQFK | 126 | Q93100 | |
| IRYFVAMKKYELENE | 481 | Q5TDP6 | |
| VNLRYGFTKEVMNKY | 246 | O14830 | |
| VFIIIVLYMLRFKKY | 166 | P18433 | |
| LFNTKQYTMELERLY | 1006 | O15294 | |
| LVSQYKFYLENLEQM | 301 | Q8WTT2 | |
| LAKRIYEAYLKNFNM | 206 | Q07869 | |
| RYTKMKTATNIYIFN | 86 | P41145 | |
| YRTLVNVVKYKLDHM | 96 | P29083 | |
| MYKSEYFIKQILLNL | 166 | Q9NYW0 | |
| TDYAVYLCKRTMQNK | 126 | P49802 | |
| AQQYDMFNIYIKRAA | 626 | Q9HCS7 | |
| KMFYSFQDKLNLYLI | 151 | Q15208 | |
| LYEDAQMARKVKQYL | 1101 | Q8TEU7 | |
| GMFQRKYLYQKVERT | 101 | Q8NBJ9 | |
| VKMFYSFQDKRNLYL | 151 | Q9Y2H1 | |
| FQTYKQMYLEKRSRS | 1726 | Q9HCM1 | |
| AYYSMIAAKQRLKDA | 906 | Q8IZX4 | |
| LKKDVLMVLVNYIYF | 201 | P29622 | |
| NDRVYYVSEKIMKLA | 41 | Q9Y221 | |
| KITEMVYNIFRILLY | 911 | Q8NFP9 | |
| TDVIILSQFMYYRLK | 81 | A1A4F0 | |
| KEVLFYLGQYIMTKR | 51 | Q00987 | |
| FAEYIQKNVQLYKMR | 56 | P49721 | |
| AVYSYRGQKQKKVML | 611 | Q86V20 | |
| ECRFKLNSYKMVYVI | 1166 | Q96ST3 | |
| IYQEIRNTDMKYKNR | 176 | P23193 | |
| AKQLRTFYQMYDKGL | 221 | Q9NSE4 | |
| MLVNFVVDKNIISYY | 81 | Q8NH51 | |
| IKGQQRMKYYELIVN | 171 | O15047 | |
| AAENMVKLYSLFLKY | 236 | Q9P2R7 | |
| YIKRYEGNMNIISSK | 116 | P59095 | |
| KQGMEYYRALKTRNV | 681 | P13798 | |
| NREIVMKYIHYKLSQ | 11 | P10415 | |
| RNLFILAYNYKMEQI | 406 | O95573 | |
| EQAFLVALYKYMKER | 321 | Q14865 | |
| EYQVAQLYMIQKKSR | 16 | O00562 | |
| KLYEDAQMARKVKQY | 966 | Q9Y4G8 | |
| RTYLVNDKAAKMYAF | 6 | Q8IWU4 | |
| QMYFKRIIFAEKQVI | 61 | I1YAP6 | |
| INLYKNMRETLVYLT | 451 | O14980 | |
| LYKDVMLENYRNLVF | 31 | Q08AN1 | |
| YLRLKFLIENKMQLY | 806 | Q13009 | |
| IKALSNQKYREMYEE | 191 | P42285 | |
| YAKIIKREEMVNYFA | 316 | Q5VZE5 | |
| KYVLGYKQTLKMIRQ | 26 | P62888 | |
| TFIERVKNMIYVLYF | 206 | P06133 | |
| NRAMAYLKIQKYEEA | 321 | Q9H6T3 | |
| QEIDQKRYFYKKMLT | 801 | Q8NDV3 | |
| RIMNLYQFIQLYKDI | 96 | Q8WVD5 | |
| FQISDKYLLAMVLVY | 81 | Q5MJ68 | |
| LVDRYLQTYKDKMTF | 346 | Q86TD4 | |
| KLFAMEFVKYYKQLQ | 386 | Q8IWV7 | |
| SLYKKVMLENYRNLV | 46 | Q6ECI4 | |
| VAYTVFQYLKMLQKL | 521 | O43847 | |
| EYSKVLQFKYFMVLI | 3251 | Q709C8 | |
| SFNYFINVEIKKIMK | 46 | Q9NW08 | |
| VYRMLFKSKAYERNE | 216 | Q13123 | |
| FVEYNKMQLSRIYPK | 586 | Q9NQ66 | |
| MYKNRLYFRSQVKGE | 1091 | Q9ULM0 | |
| LYFQLKSKDFVQVMR | 2411 | P78527 | |
| LKMKQDAQVVLYRSY | 2761 | P78527 | |
| ILVKSKAFQYFMYLV | 436 | Q9ULQ1 | |
| NYNEKIYELRVMETK | 161 | Q92890 | |
| LRAIYELQMKKTDYF | 2481 | O43149 | |
| LKDMKVLYTNRAQAY | 136 | Q9H892 | |
| QAKYKNITKEVIMLY | 331 | Q6R2W3 | |
| FLKIMFSYNNKELII | 61 | A0A576 | |
| AVAQYQMIIKKKEDY | 651 | Q6PGP7 | |
| VKMTKLRVVQYYGNF | 76 | Q8IW00 | |
| MAQLQTRFYTDNKKY | 1 | Q9GZL7 | |
| VYFTNELKQMQDKYS | 36 | P50591 | |
| LNYTYLISILKDMKQ | 601 | O75127 | |
| VFQLQRLVSTMSKYY | 331 | Q9NRD5 | |
| KESAYMLFYRKSQLQ | 471 | Q9NVE5 | |
| LYYQQLKMKITDFEN | 876 | Q93009 | |
| LKLQDSMSIFKYLRY | 876 | Q9UPU7 | |
| YENYMKRKELQNTVS | 211 | Q7L0Y3 | |
| SSQRKLYKDVMLENY | 76 | Q96PQ6 | |
| SVVKDYMLFRKYNLQ | 251 | Q9NXG2 | |
| YMLFRKYNLQEVVKS | 256 | Q9NXG2 | |
| SSLKFIRYIYVNLKM | 591 | O15321 | |
| LFREKDYKQALVQYM | 46 | Q9UGR2 | |
| MNIEIIRNTLYKAYL | 176 | P61421 | |
| VENLKKRYMDDYIFT | 36 | Q12965 | |
| KYYHVEQLNLMRKEA | 1041 | Q8NEV4 | |
| TEEFVQMNYLKYQRV | 236 | Q99608 | |
| ARYLKEYQDLLNVKM | 366 | P07196 |